Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cytoskeletal motor activity	KIF13B MYH1 MYH2 MYH4 KIF27 MYO7A MYO7B MYO10 MYH7B MYO1B DNAH7 KIF24 DNAH17 KIF5A KIF5C KIF13A	3.72e-15	118	169	16	GO:0003774
GeneOntologyMolecularFunction	ATP-dependent activity	KIF13B MYH1 MYH2 ATP6V1B2 MYH4 KIF27 MYO7A MYO7B MYO10 MYH7B RNF213 MYO1B CHD8 CHD7 DDX55 ATAD2 DNAH7 KIF24 ABCA8 DNAH17 HLTF HFM1 KIF5A KIF5C MTREX KIF13A	1.28e-11	614	169	26	GO:0140657
GeneOntologyMolecularFunction	cytoskeletal protein binding	KIF13B MYH1 MYH2 FLNB FLNC MYH4 ABL1 KIF27 MYO7A SYNM MYO7B MYO10 MARK1 MYH7B INPPL1 RUSC1 EML2 TOGARAM1 MYO1B CLIP1 KIF24 KPTN NEFM NF1 XIRP2 TLN1 MAST1 KIF5A KIF5C FUS KIF13A EPB41L1 EPB41L2 VCL	3.78e-11	1099	169	34	GO:0008092
GeneOntologyMolecularFunction	microfilament motor activity	MYH1 MYH2 MYH4 MYO7A MYO7B MYO10 MYH7B MYO1B	8.78e-10	38	169	8	GO:0000146
GeneOntologyMolecularFunction	actin filament binding	MYH1 MYH2 FLNB FLNC MYH4 ABL1 MYO7A MYO7B MYO10 MYH7B MYO1B KPTN XIRP2 TLN1 VCL	9.69e-10	227	169	15	GO:0051015
GeneOntologyMolecularFunction	actin binding	MYH1 MYH2 FLNB FLNC MYH4 ABL1 MYO7A MYO7B MYO10 MYH7B INPPL1 RUSC1 MYO1B KPTN XIRP2 TLN1 EPB41L1 EPB41L2 VCL	2.59e-08	479	169	19	GO:0003779
GeneOntologyMolecularFunction	microtubule motor activity	KIF13B KIF27 DNAH7 KIF24 DNAH17 KIF5A KIF5C KIF13A	1.35e-07	70	169	8	GO:0003777
GeneOntologyMolecularFunction	ATP hydrolysis activity	KIF13B MYH4 KIF27 RNF213 CHD8 CHD7 DDX55 ATAD2 DNAH7 ABCA8 HFM1 KIF5A KIF5C MTREX KIF13A	5.44e-06	441	169	15	GO:0016887
GeneOntologyMolecularFunction	benzodiazepine receptor binding	RIMBP3 RIMBP3C RIMBP3B	5.88e-06	5	169	3	GO:0030156
GeneOntologyMolecularFunction	microtubule binding	KIF13B KIF27 EML2 TOGARAM1 CLIP1 KIF24 NEFM NF1 MAST1 KIF5A KIF5C KIF13A	1.29e-05	308	169	12	GO:0008017
GeneOntologyMolecularFunction	nuclear thyroid hormone receptor binding	NCOA3 MED1 TACC1 FUS	1.88e-04	34	169	4	GO:0046966
GeneOntologyMolecularFunction	tubulin binding	KIF13B KIF27 EML2 TOGARAM1 CLIP1 KIF24 NEFM NF1 MAST1 KIF5A KIF5C KIF13A	2.97e-04	428	169	12	GO:0015631
GeneOntologyMolecularFunction	peroxisome proliferator activated receptor binding	NCOA3 MED1 TACC1	7.08e-04	21	169	3	GO:0042975
GeneOntologyMolecularFunction	phosphatidylinositol-3,4,5-trisphosphate binding	MYO10 INPPL1 MYO1B WASHC2A	7.80e-04	49	169	4	GO:0005547
GeneOntologyMolecularFunction	nuclear estrogen receptor binding	NCOA3 MED1 TACC1 FUS	1.05e-03	53	169	4	GO:0030331
GeneOntologyMolecularFunction	3-chloroallyl aldehyde dehydrogenase activity	ALDH1A2 ALDH1A3	1.45e-03	7	169	2	GO:0004028
GeneOntologyCellularComponent	myosin complex	MYH1 MYH2 MYH4 MYO7A MYO7B MYO10 MYH7B MYO1B	2.53e-08	59	170	8	GO:0016459
GeneOntologyCellularComponent	actin-based cell projection	KIF13B ATP6V1B2 MYO7A MYO7B CDHR2 MYO10 SLC26A2 INPPL1 MYO1B KPTN FAT1 MTM1 ANKRD24	4.77e-07	278	170	13	GO:0098858
GeneOntologyCellularComponent	supramolecular fiber	KIF13B MYH1 MYH2 FLNB FLNC MYH4 KIF27 SYNM MYH7B RUSC1 EML2 TOGARAM1 MYO1B SPECC1 CLIP1 DNAH7 KIF24 KPTN NEFM XIRP2 MTM1 DNAH17 AK1 KIF5A KIF5C KIF13A VCL	1.03e-06	1179	170	27	GO:0099512
GeneOntologyCellularComponent	actin cytoskeleton	MYH1 MYH2 FLNB FLNC MYH4 ABL1 MYO7A MYO7B MYO10 MYH7B MYO1B FOXA3 SPECC1 KPTN XIRP2 PEAK1 EPB41L2 VCL	1.15e-06	576	170	18	GO:0015629
GeneOntologyCellularComponent	supramolecular polymer	KIF13B MYH1 MYH2 FLNB FLNC MYH4 KIF27 SYNM MYH7B RUSC1 EML2 TOGARAM1 MYO1B SPECC1 CLIP1 DNAH7 KIF24 KPTN NEFM XIRP2 MTM1 DNAH17 AK1 KIF5A KIF5C KIF13A VCL	1.18e-06	1187	170	27	GO:0099081
GeneOntologyCellularComponent	myofibril	MYH1 MYH2 FLNB FLNC MYH4 SYNM MYH7B XIRP2 MTM1 AK1 VCL	1.52e-05	273	170	11	GO:0030016
GeneOntologyCellularComponent	contractile muscle fiber	MYH1 MYH2 FLNB FLNC MYH4 SYNM MYH7B XIRP2 MTM1 AK1 VCL	2.66e-05	290	170	11	GO:0043292
GeneOntologyCellularComponent	sarcomere	MYH1 MYH2 FLNB FLNC MYH4 SYNM XIRP2 MTM1 AK1 VCL	3.85e-05	249	170	10	GO:0030017
GeneOntologyCellularComponent	myosin filament	MYH1 MYH2 MYH4 MYH7B	4.67e-05	25	170	4	GO:0032982
GeneOntologyCellularComponent	kinesin complex	KIF13B KIF27 KIF5A KIF5C KIF13A	4.79e-05	49	170	5	GO:0005871
GeneOntologyCellularComponent	microtubule associated complex	KIF13B KIF27 EML2 DNAH7 DNAH17 KIF5A KIF5C KIF13A	5.30e-05	161	170	8	GO:0005875
GeneOntologyCellularComponent	microvillus	KIF13B ATP6V1B2 MYO7A MYO7B CDHR2 SLC26A2 MYO1B	6.69e-05	123	170	7	GO:0005902
GeneOntologyCellularComponent	myosin II complex	MYH1 MYH2 MYH4 MYH7B	7.42e-05	28	170	4	GO:0016460
GeneOntologyCellularComponent	cluster of actin-based cell projections	FLNB MYO7A MYO7B CDHR2 RAPGEF4 MYO1B KPTN ANKRD24 SLC6A14	9.09e-05	223	170	9	GO:0098862
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	KIF13B KIF27 SYNM RUSC1 EML2 TOGARAM1 MYO1B SPECC1 CLIP1 DNAH7 KIF24 KPTN NEFM DNAH17 AK1 KIF5A KIF5C KIF13A VCL	1.37e-04	899	170	19	GO:0099513
GeneOntologyCellularComponent	muscle myosin complex	MYH1 MYH2 MYH4	2.74e-04	16	170	3	GO:0005859
GeneOntologyCellularComponent	costamere	FLNC SYNM VCL	7.26e-04	22	170	3	GO:0043034
GeneOntologyCellularComponent	microtubule	KIF13B KIF27 RUSC1 EML2 TOGARAM1 CLIP1 DNAH7 KIF24 DNAH17 KIF5A KIF5C KIF13A	1.43e-03	533	170	12	GO:0005874
GeneOntologyCellularComponent	manchette	RIMBP3 RIMBP3C RIMBP3B	1.49e-03	28	170	3	GO:0002177
GeneOntologyCellularComponent	brush border	FLNB MYO7B CDHR2 RAPGEF4 MYO1B SLC6A14	1.54e-03	152	170	6	GO:0005903
GeneOntologyCellularComponent	postsynapse	DOCK1 CACNA2D1 ABL1 RPLP0 MARK1 RAPGEF4 RUSC1 RTN3 NR3C1 KPTN NEFM RNF220 PLCB4 KIF5A KIF5C FUS CDH10 EPB41L1	1.64e-03	1018	170	18	GO:0098794
GeneOntologyCellularComponent	MLL1 complex	CHD8 KMT2A MCRS1	2.20e-03	32	170	3	GO:0071339
GeneOntologyCellularComponent	I band	FLNB FLNC SYNM XIRP2 MTM1 VCL	2.41e-03	166	170	6	GO:0031674
GeneOntologyCellularComponent	MLL1/2 complex	CHD8 KMT2A MCRS1	2.41e-03	33	170	3	GO:0044665
GeneOntologyCellularComponent	anchoring junction	MYH1 MYH2 FLNB FLNC RPLP0 SYNM CDHR2 MAGI3 FAT1 CDH22 UBN1 XIRP2 TLN1 PEAK1 CDH10 EPB41L2 VCL	2.58e-03	976	170	17	GO:0070161
GeneOntologyCellularComponent	lipid droplet	PLIN4 CES1 RNF213 APOB PLIN2	2.60e-03	116	170	5	GO:0005811
MousePheno	abnormal gas homeostasis	DOCK1 DOK1 NCOA3 FLNC SYNM CES1 INPPL1 CHD7 CCDC92 NR3C1 FOXA3 SLC38A10 ALDH1A2 VCAN RNF20 KIF5A FUS ALDH1A3	1.50e-05	600	133	18	MP:0003948
MousePheno	increased oxygen consumption	DOK1 NCOA3 SYNM CES1 CHD7 CCDC92 FOXA3 SLC38A10	1.99e-05	121	133	8	MP:0005289
MousePheno	ectopic manchette	CLIP1 RIMBP3 RIMBP3C RIMBP3B	2.72e-05	19	133	4	MP:0009377
MousePheno	abnormal internal nares morphology	KIF27 CHD7 ALDH1A3	2.87e-05	7	133	3	MP:0002236
MousePheno	abnormal atrioventricular cushion morphology	CHD7 ALDH1A2 NF1 VCAN VCL NPAT	8.39e-05	76	133	6	MP:0000297
MousePheno	decreased circulating cholesterol level	NCOA3 DMXL2 CES1 MYH7B INPPL1 APOB CHD7 CCDC92 FOXA3 LDLR ABCA8 MALRD1 PEAK1	1.05e-04	397	133	13	MP:0005179
MousePheno	abnormal fetal atrioventricular canal morphology	CHD7 ALDH1A2 NF1 VCAN VCL NPAT	1.20e-04	81	133	6	MP:0006107
Domain	Myosin_head_motor_dom	MYH1 MYH2 MYH4 MYO7A MYO7B MYO10 MYH7B MYO1B	1.41e-09	38	168	8	IPR001609
Domain	MYOSIN_MOTOR	MYH1 MYH2 MYH4 MYO7A MYO7B MYO10 MYH7B MYO1B	1.41e-09	38	168	8	PS51456
Domain	Myosin_head	MYH1 MYH2 MYH4 MYO7A MYO7B MYO10 MYH7B MYO1B	1.41e-09	38	168	8	PF00063
Domain	MYSc	MYH1 MYH2 MYH4 MYO7A MYO7B MYO10 MYH7B MYO1B	1.41e-09	38	168	8	SM00242
Domain	P-loop_NTPase	KIF13B MYH1 MYH2 ATP6V1B2 MYH4 KIF27 MYO7A MYO7B MYO10 MYH7B RNF213 MAGI3 MYO1B CHD8 CHD7 DDX55 ATAD2 DNAH7 KIF24 ABCA8 HLTF AK1 HFM1 KIF5A KIF5C MTREX KIF13A	1.00e-08	848	168	27	IPR027417
Domain	IQ	MYH1 MYH2 MYH4 MYO7A MYO7B MYO10 MYH7B MYO1B	6.68e-07	81	168	8	SM00015
Domain	IQ_motif_EF-hand-BS	MYH1 MYH2 MYH4 MYO7A MYO7B MYO10 MYH7B MYO1B	1.50e-06	90	168	8	IPR000048
Domain	Kinesin_motor_CS	KIF13B KIF27 KIF24 KIF5A KIF5C KIF13A	1.68e-06	41	168	6	IPR019821
Domain	IQ	MYH1 MYH2 MYH4 MYO7A MYO7B MYO10 MYH7B MYO1B	1.93e-06	93	168	8	PS50096
Domain	Kinesin-like_fam	KIF13B KIF27 KIF24 KIF5A KIF5C KIF13A	2.24e-06	43	168	6	IPR027640
Domain	-	KIF13B KIF27 KIF24 KIF5A KIF5C KIF13A	2.58e-06	44	168	6	3.40.850.10
Domain	Kinesin	KIF13B KIF27 KIF24 KIF5A KIF5C KIF13A	2.58e-06	44	168	6	PF00225
Domain	KISc	KIF13B KIF27 KIF24 KIF5A KIF5C KIF13A	2.58e-06	44	168	6	SM00129
Domain	KINESIN_MOTOR_1	KIF13B KIF27 KIF24 KIF5A KIF5C KIF13A	2.58e-06	44	168	6	PS00411
Domain	Kinesin_motor_dom	KIF13B KIF27 KIF24 KIF5A KIF5C KIF13A	2.58e-06	44	168	6	IPR001752
Domain	KINESIN_MOTOR_2	KIF13B KIF27 KIF24 KIF5A KIF5C KIF13A	2.58e-06	44	168	6	PS50067
Domain	FERM_M	MYO7A MYO7B MYO10 TLN1 EPB41L1 EPB41L2	3.37e-06	46	168	6	PF00373
Domain	IQ	MYH1 MYH2 MYH4 MYO7A MYO7B MYO10 MYO1B	3.45e-06	71	168	7	PF00612
Domain	-	MYO7A MYO7B MYO10 TLN1 EPB41L1 EPB41L2	4.92e-06	49	168	6	1.20.80.10
Domain	FERM_central	MYO7A MYO7B MYO10 TLN1 EPB41L1 EPB41L2	4.92e-06	49	168	6	IPR019748
Domain	FERM_domain	MYO7A MYO7B MYO10 TLN1 EPB41L1 EPB41L2	4.92e-06	49	168	6	IPR000299
Domain	FERM/acyl-CoA-bd_prot_3-hlx	MYO7A MYO7B MYO10 TLN1 EPB41L1 EPB41L2	5.55e-06	50	168	6	IPR014352
Domain	FERM_1	MYO7A MYO7B MYO10 TLN1 EPB41L1 EPB41L2	5.55e-06	50	168	6	PS00660
Domain	FERM_2	MYO7A MYO7B MYO10 TLN1 EPB41L1 EPB41L2	5.55e-06	50	168	6	PS00661
Domain	FERM_3	MYO7A MYO7B MYO10 TLN1 EPB41L1 EPB41L2	5.55e-06	50	168	6	PS50057
Domain	Band_41_domain	MYO7A MYO7B MYO10 TLN1 EPB41L1 EPB41L2	5.55e-06	50	168	6	IPR019749
Domain	B41	MYO7A MYO7B MYO10 TLN1 EPB41L1 EPB41L2	5.55e-06	50	168	6	SM00295
Domain	Myosin_N	MYH1 MYH2 MYH4 MYH7B	7.98e-06	15	168	4	PF02736
Domain	Myosin_N	MYH1 MYH2 MYH4 MYH7B	7.98e-06	15	168	4	IPR004009
Domain	Myosin_tail_1	MYH1 MYH2 MYH4 MYH7B	1.75e-05	18	168	4	PF01576
Domain	Myosin_tail	MYH1 MYH2 MYH4 MYH7B	1.75e-05	18	168	4	IPR002928
Domain	Myosin-like_IQ_dom	MYH1 MYH2 MYH4 MYH7B	2.20e-05	19	168	4	IPR027401
Domain	-	MYH1 MYH2 MYH4 MYH7B	2.20e-05	19	168	4	4.10.270.10
Domain	MYTH4	MYO7A MYO7B MYO10	5.77e-05	9	168	3	PS51016
Domain	MyTH4	MYO7A MYO7B MYO10	5.77e-05	9	168	3	SM00139
Domain	MyTH4_dom	MYO7A MYO7B MYO10	5.77e-05	9	168	3	IPR000857
Domain	MyTH4	MYO7A MYO7B MYO10	5.77e-05	9	168	3	PF00784
Domain	ARM-type_fold	MON2 DOCK1 IPO5 CUL9 TOGARAM1 APOB ARMCX1 RIF1 NF1 PIK3C2G RRP12 PPP6R2	5.92e-05	339	168	12	IPR016024
Domain	Filamin	FLNB FLNC MYCBP2	1.12e-04	11	168	3	PF00630
Domain	FILAMIN_REPEAT	FLNB FLNC MYCBP2	1.12e-04	11	168	3	PS50194
Domain	Filamin/ABP280_rpt	FLNB FLNC MYCBP2	1.12e-04	11	168	3	IPR001298
Domain	Filamin/ABP280_repeat-like	FLNB FLNC MYCBP2	1.12e-04	11	168	3	IPR017868
Domain	ARM-like	MON2 IPO5 CUL9 TOGARAM1 ATAD2 ARMCX1 RIF1 NF1 RRP12 PPP6R2	1.71e-04	270	168	10	IPR011989
Domain	-	MON2 IPO5 CUL9 TOGARAM1 ATAD2 ARMCX1 RIF1 NF1 RRP12	1.86e-04	222	168	9	1.25.10.10
Domain	FERM_N	MYO7A TLN1 EPB41L1 EPB41L2	2.11e-04	33	168	4	IPR018979
Domain	FERM_N	MYO7A TLN1 EPB41L1 EPB41L2	2.11e-04	33	168	4	PF09379
Domain	Helicase_C	CHD8 CHD7 DDX55 HLTF HFM1 MTREX	4.14e-04	107	168	6	PF00271
Domain	HELICc	CHD8 CHD7 DDX55 HLTF HFM1 MTREX	4.14e-04	107	168	6	SM00490
Domain	Helicase_C	CHD8 CHD7 DDX55 HLTF HFM1 MTREX	4.35e-04	108	168	6	IPR001650
Domain	HELICASE_CTER	CHD8 CHD7 DDX55 HLTF HFM1 MTREX	4.57e-04	109	168	6	PS51194
Domain	HELICASE_ATP_BIND_1	CHD8 CHD7 DDX55 HLTF HFM1 MTREX	4.57e-04	109	168	6	PS51192
Domain	DEXDc	CHD8 CHD7 DDX55 HLTF HFM1 MTREX	4.57e-04	109	168	6	SM00487
Domain	Kinesin-like_KIF1-typ	KIF13B KIF13A	4.77e-04	4	168	2	IPR022140
Domain	4_1_CTD	EPB41L1 EPB41L2	4.77e-04	4	168	2	PF05902
Domain	KIF1B	KIF13B KIF13A	4.77e-04	4	168	2	PF12423
Domain	SAB	EPB41L1 EPB41L2	4.77e-04	4	168	2	PF04382
Domain	Band_4.1_C	EPB41L1 EPB41L2	4.77e-04	4	168	2	IPR008379
Domain	SAB_dom	EPB41L1 EPB41L2	4.77e-04	4	168	2	IPR007477
Domain	Helicase_ATP-bd	CHD8 CHD7 DDX55 HLTF HFM1 MTREX	4.80e-04	110	168	6	IPR014001
Domain	SH3_9	DOCK1 RUSC1 RIMBP3 RIMBP3C RIMBP3B	6.90e-04	78	168	5	PF14604
Domain	SH3	DOCK1 ABL1 MYO7A MYO7B RUSC1 RIMBP3 RIMBP3C RIMBP3B	7.69e-04	216	168	8	SM00326
Domain	SH3	DOCK1 ABL1 MYO7A MYO7B RUSC1 RIMBP3 RIMBP3C RIMBP3B	7.69e-04	216	168	8	PS50002
Domain	Perilipin	PLIN4 PLIN2	7.90e-04	5	168	2	PF03036
Domain	Perilipin	PLIN4 PLIN2	7.90e-04	5	168	2	IPR004279
Domain	SH3_domain	DOCK1 ABL1 MYO7A MYO7B RUSC1 RIMBP3 RIMBP3C RIMBP3B	8.66e-04	220	168	8	IPR001452
Domain	BRK	CHD8 CHD7	1.18e-03	6	168	2	SM00592
Domain	Kinesin_assoc	KIF13B KIF13A	1.18e-03	6	168	2	PF16183
Domain	BRK_domain	CHD8 CHD7	1.18e-03	6	168	2	IPR006576
Domain	Kinesin-like	KIF13B KIF13A	1.18e-03	6	168	2	IPR022164
Domain	Kinesin_assoc	KIF13B KIF13A	1.18e-03	6	168	2	IPR032405
Domain	DUF3694	KIF13B KIF13A	1.18e-03	6	168	2	PF12473
Domain	BRK	CHD8 CHD7	1.18e-03	6	168	2	PF07533
Domain	FERM_CS	TLN1 EPB41L1 EPB41L2	1.26e-03	24	168	3	IPR019747
Domain	Ubiquitin-rel_dom	MYO7A MYO7B RAPGEF4 PIK3C2G TLN1 EPB41L1 EPB41L2	1.40e-03	184	168	7	IPR029071
Domain	APC_su10/DOC_dom	MYCBP2 CUL9	1.64e-03	7	168	2	IPR004939
Domain	Vinculin/catenin	TLN1 VCL	1.64e-03	7	168	2	IPR006077
Domain	DOC	MYCBP2 CUL9	1.64e-03	7	168	2	PS51284
Domain	ANAPC10	MYCBP2 CUL9	1.64e-03	7	168	2	PF03256
Domain	APC10	MYCBP2 CUL9	1.64e-03	7	168	2	SM01337
Domain	RING	MYCBP2 CUL9 RNF213 NSD3 TRIM33 RNF220 RNF20 HLTF OBI1	1.80e-03	305	168	9	SM00184
Domain	FHA	KIF13B MCRS1 KIF13A	1.99e-03	28	168	3	SM00240
Domain	FHA_DOMAIN	KIF13B MCRS1 KIF13A	2.67e-03	31	168	3	PS50006
Domain	FHA	KIF13B MCRS1 KIF13A	2.67e-03	31	168	3	PF00498
Domain	Znf_RING	MYCBP2 CUL9 RNF213 NSD3 TRIM33 RNF220 RNF20 HLTF OBI1	2.82e-03	326	168	9	IPR001841
Domain	SNF2_N	CHD8 CHD7 HLTF	2.93e-03	32	168	3	IPR000330
Domain	SNF2_N	CHD8 CHD7 HLTF	2.93e-03	32	168	3	PF00176
Domain	IG_FLMN	FLNB FLNC	3.45e-03	10	168	2	SM00557
Domain	-	RBM10 FUS	3.45e-03	10	168	2	4.10.1060.10
Domain	CAP_GLY	KIF13B CLIP1	3.45e-03	10	168	2	PF01302
Domain	CAP_GLY	KIF13B CLIP1	3.45e-03	10	168	2	SM01052
Domain	-	KIF13B CLIP1	3.45e-03	10	168	2	2.30.30.190
Domain	CAP_GLY_1	KIF13B CLIP1	3.45e-03	10	168	2	PS00845
Domain	CAP_GLY_2	KIF13B CLIP1	3.45e-03	10	168	2	PS50245
Domain	CAP-Gly_domain	KIF13B CLIP1	3.45e-03	10	168	2	IPR000938
Domain	Prefoldin	CCDC92 SPECC1 RNF20 OBI1	4.04e-03	72	168	4	IPR009053
Domain	-	KIF13B MCRS1 KIF13A	4.11e-03	36	168	3	2.60.200.20
Domain	FHA_dom	KIF13B MCRS1 KIF13A	4.11e-03	36	168	3	IPR000253
Domain	PH_dom-like	DOK1 MYO7A MYO7B MYO10 MYO1B TLN1 MTM1 PLCB4 EPB41L1 EPB41L2	5.29e-03	426	168	10	IPR011993
Domain	ZF_RING_2	MYCBP2 CUL9 RNF213 TRIM33 RNF220 RNF20 HLTF OBI1	5.65e-03	298	168	8	PS50089
Domain	FA	EPB41L1 EPB41L2	5.88e-03	13	168	2	PF08736
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	IPO5 FLNB FLNC RPLP0 MYCBP2 CUL9 MYO1B CHD8 CHD7 NUP214 ATAD2 TTF1 PRKRA GMPS NEFM RIF1 NF1 TLN1 RRP12 SLTM KMT2A HADHA UQCRC2 FUS MTREX EPB41L2 VCL	2.74e-17	653	172	27	22586326
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	EFCAB5 KIF13B MYH1 MYH2 FLNB FLNC MYH4 RPLP0 CES1 MYH7B DTL MAGI3 MYO1B SRSF11 APOB MDH2 DDX55 PSMA8 ERLEC1 NEFM BBX PYCR1 KMT2A CC2D2A CDNF AK1 BOD1L1 HADHA KIF5A KIF5C UQCRC2 FUS OBI1 SLC6A14	2.82e-14	1442	172	34	35575683
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	FOXM1 MON2 KIF13B INPPL1 DTL RTN3 CUL9 MYO1B CHD7 NR3C1 WASHC2A RIMBP3 KANSL3 TRIM33 ALDH1A2 UBN1 MTREX PPP6R2 OBI1 FKBP5	1.63e-11	588	172	20	38580884
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	IPO5 FLNB CACNA2D1 ATP6V1B2 FLNC DMXL2 RPLP0 MYO7A MARK1 IGHV1-45 RAPGEF4 RTN3 MDH2 SPECC1 PRKRA NEFM NF1 VCAN TLN1 FGA MAST1 KMT2A HADHA KIF5C UQCRC2 PEAK1 PPP6R2 EPB41L1 EPB41L2 VCL	2.12e-11	1431	172	30	37142655
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	IPO5 FLNB CACNA2D1 ATP6V1B2 RPLP0 MYCBP2 RTN3 MYO1B SRSF11 APOB NUP214 MDH2 DDX55 SPECC1 LDLR ERLEC1 NSD3 GMPS FAT1 SLTM CNPY3 BOD1L1 PLCB4 HADHA UQCRC2 FUS EPB41L2 RBM17	5.52e-11	1297	172	28	33545068
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	IPO5 FLNB CACNA2D1 ATP6V1B2 FLNC RPLP0 MYCBP2 RBM10 MYO1B SRSF11 NUP214 MDH2 SPECC1 RIF1 NF1 TLN1 RRP12 SLTM HADHA UQCRC2 FUS MTREX EPB41L2 RBM17	2.97e-10	1024	172	24	24711643
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	RPLP0 RPLP0P6 RBM10 SRSF11 CHD8 CHD7 NUP214 MED1 NSD3 NDUFV3 YTHDF1 TRIM33 RIF1 BBX UBN1 SLTM KMT2A BOD1L1 QSER1 UQCRC2 FUS RBM17 NPAT	4.19e-10	954	172	23	36373674
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	MYH2 FLNB SYNM MYH7B RBM10 DTL RNF213 NUP214 DDX55 RIF1 RRP12 HFM1 VCL	4.23e-10	250	172	13	33536335
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	MON2 FLNB DMXL2 RPLP0 MYCBP2 MARK1 BSDC1 RTN3 WASHC2A WDR26 PRKRA GMPS YTHDF1 NF1 GUCY1B1 AK1 TACC1 HADHA UQCRC2 PEAK1 PPP6R2 FKBP2 EPB41L1 EPB41L2 RBM17	4.73e-10	1139	172	25	36417873
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MON2 SDSL FLNC ABL1 MYCBP2 MYO7A MYO10 INPPL1 CUL9 EML2 CHD8 NUP214 WASHC2A LDLR NSD3 KANSL3 ESRP2 FAT1 SLC38A10 UBN1 TLN1 RRP12 PCNX1 HMGXB3	1.34e-09	1105	172	24	35748872
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	MYCBP2 BSDC1 RUSC1 MYO1B SRSF11 CHD8 WASHC2A SPECC1 WDR26 HMCES PLIN2 TRIM33 RNF220 FAT1 NF1 R3HCC1L UBN1 VCAN FGA CNPY3 CDNF ANKRD24 HADHA NOVA1 RBM17	1.76e-09	1215	172	25	15146197
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	FOXM1 NCOA3 RPLP0 MYCBP2 RBM10 CHD7 NUP214 MED1 ATAD2 CLIP1 KANSL3 FBXO38 RIF1 NF1 UBN1 RRP12 RNF20 KMT2A FKBP5 EPB41L2	1.97e-09	774	172	20	15302935
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	KIF13B ABL1 MYCBP2 INPPL1 DTL MAGI3 SRSF11 SPECC1 WDR26 DNAH7 NSD3 NF1 KMT2A BOD1L1 KIF5C PEAK1 MTREX KIF13A OBI1 EPB41L1 EPB41L2	2.09e-09	861	172	21	36931259
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	IPO5 FLNB KIF27 RPLP0 RTN3 MYO1B APOB NUP214 MDH2 DDX55 ATAD2 RIF1 NF1 TLN1 RRP12 RNF20 SLTM PYCR1 CC2D2A BOD1L1 HADHA UQCRC2 FUS PEAK1 MTREX EPB41L2 VCL	2.16e-09	1425	172	27	30948266
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PLIN4 KIF13B DMXL2 SYNM MARK1 RNF213 MAGI3 TOGARAM1 ZNF623 ABCA8 DNAH17 WDR35 ANKRD24 ZNF518B PEAK1 PPP6R2	3.76e-09	493	172	16	15368895
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	FLNC DMXL2 RELN RPLP0 MYCBP2 MARK1 RBM10 MYO1B SRSF11 CHD7 MED1 DDX55 INTS8 NSD3 PRKRA NEFM BBX VCAN RRP12 SLTM HADHA UQCRC2 RBM17	4.58e-09	1082	172	23	38697112
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	IPO5 FLNB ATP6V1B2 DMXL2 RELN MYCBP2 SYNM RAPGEF4 CUL9 MAGI3 SPECC1 INTS8 WDR26 PRKRA NEFM TRIM33 RNF220 GUCY1B1 MTM1 MAST1 MCRS1 ANKRD24 ANKRD36 KIF5A KIF5C	5.41e-09	1285	172	25	35914814
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	DOCK1 IPO5 KIF27 RBM10 SRSF11 CHD8 CHD7 INTS8 GMPS RIF1 NF1 UBN1 TLN1 HLTF FUS MTREX RBM17	5.74e-09	582	172	17	20467437
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	IPO5 NCOA3 RNF213 CHD8 MED1 WDR26 NSD3 GMPS KANSL3 TRIM33 RIF1 UBN1 RNF20 SLTM HLTF KMT2A AK1 BOD1L1 QSER1 MTREX FKBP5 RBM17	7.08e-09	1014	172	22	32416067
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	NCOA3 RBM10 CHD8 CHD7 MED1 KANSL3 TRIM33 RNF20 KMT2A MCRS1 QSER1 RBM17	1.09e-08	268	172	12	33640491
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	IPO5 CHD8 CHD7 MED1 DDX55 ATAD2 NSD3 FBXO38 RNF220 RIF1 BBX UBN1 HLTF KMT2A BOD1L1 QSER1 NPAT	1.09e-08	608	172	17	36089195
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	IPO5 FLNB ABL1 MYO10 CHD8 PSMA8 LDLR FAT1 UBN1 TLN1 HMGXB3 TACC1 ZNF518B	1.29e-08	332	172	13	37433992
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	FLNB FLNC MYCBP2 MYO1B CHD8 CHD7 NUP214 ATAD2 ARMCX1 PRKRA GMPS RIF1 NF1 UBN1 TLN1 RRP12 RNF20 SLTM HLTF PYCR1 HADHA UQCRC2 MTREX EPB41L2 VCL	1.49e-08	1353	172	25	29467282
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	IPO5 FLNB FLNC RPLP0 MYCBP2 MUC19 RTN3 MYO1B CHD8 MDH2 TLN1 RNF20 SLTM KMT2A PCNX1 HADHA FUS PEAK1 VCL	2.26e-08	807	172	19	30575818
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	RBM10 SRSF11 CHD7 NUP214 MED1 TTF1 LDLR NSD3 KANSL3 RIF1 BBX UBN1 RRP12 RNF20 SLTM HLTF KMT2A MCRS1 NKTR HADHA QSER1 FUS MTREX RBM17	2.79e-08	1294	172	24	30804502
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	IPO5 KIF13B MYH2 FLNB FLNC MYH4 MYCBP2 MYO10 MARK1 DTL MAGI3 NUP214 WDR26 GMPS YTHDF1 FBXO38 RNF220 HLTF HADHA PPP6R2 FKBP5	3.04e-08	1005	172	21	19615732
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	DOCK1 NCOA3 FLNB DTL CHD8 MED1 CLIP1 RIF1 MTM1 RRP12 MCRS1 KIF13A OBI1 EPB41L1 EPB41L2	3.60e-08	503	172	15	16964243
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	FLNB RPLP0 MYO1B SRSF11 MED1 MDH2 WASHC2A RIF1 TLN1 RNF20 BOD1L1 HADHA FUS VCL RBM17	3.89e-08	506	172	15	30890647
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	RPLP0 RBM10 MYO1B NUP214 NR3C1 MED1 MDH2 GMPS RIF1 ALDH1A2 R3HCC1L TLN1 RRP12 KMT2A BOD1L1 TACC1 PPP6R2 EPB41L2 VCL RBM17	4.47e-08	934	172	20	33916271
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	MON2 IPO5 MYH2 FLNB CACNA2D1 RNF213 MYO1B SRSF11 MDH2 SPECC1 WDR26 ERLEC1 PRKRA AKTIP UBN1 TLN1 RRP12 HLTF PYCR1 KMT2A HADHA UQCRC2 MTREX FKBP5 RBM17	5.00e-08	1440	172	25	30833792
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	FOXM1 FLNC CHD8 NR3C1 MED1 HMCES KANSL3 TRIM33 RNF220 UBN1 TLN1 RNF20 SLTM EPB41L2	5.27e-08	444	172	14	34795231
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	IPO5 FLNB FLNC RPLP0 MYCBP2 RBM10 MYO1B NR3C1 MDH2 WDR26 PRKRA GMPS NEFM TLN1 RRP12 PYCR1 HADHA FUS OBI1 FKBP5 EPB41L2 VCL	6.44e-08	1149	172	22	35446349
Pubmed	Different splice variants of filamin-B affect myogenesis, subcellular distribution, and determine binding to integrin [beta] subunits.	FLNB FLNC TLN1 VCL	7.14e-08	9	172	4	11807098
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	KIF13B NCOA3 CACNA2D1 DMXL2 MYCBP2 RAPGEF4 CHD8 CHD7 WDR26 CLIP1 NEFM NF1 KIF5A KIF5C QSER1 FUS PPP6R2 CDH10 EPB41L1 EPB41L2	7.33e-08	963	172	20	28671696
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	FLNB FLNC RPLP0 RBM10 MYO1B SRSF11 ATAD2 TRIM33 RIF1 RRP12 RNF20 SLTM HLTF PYCR1 BOD1L1 HADHA UQCRC2 FUS MTREX VCL	1.12e-07	989	172	20	36424410
Pubmed	Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation.	MYH1 MYH2 MYH4	1.19e-07	3	172	3	26059207
Pubmed	Mapping of unconventional myosins in mouse and human.	MYH4 MYO7A MYO7B MYO10 MYO1B NF1	1.38e-07	48	172	6	8884266
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	FOXM1 FLNB ATP6V1B2 MYCBP2 MED1 DDX55 ATAD2 NSD3 BBX UBN1 TLN1 RNF20 SLTM KMT2A HADHA KIF5A	1.54e-07	645	172	16	25281560
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	SEMG2 FLNB RPLP0 APOB MDH2 ATAD2 NDUFV3 NEFM RIF1 TLN1 RRP12 SLTM FGA UQCRC2 FUS MTREX	1.78e-07	652	172	16	31180492
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	IPO5 CUL9 CHD8 CHD7 NUP214 WASHC2A WDR26 TRIM33 BOD1L1 QSER1 MTREX	1.82e-07	282	172	11	23667531
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	FOXM1 MON2 IPO5 MYO10 SLC26A2 OR9I1 INPPL1 DTL CHD8 NUP214 MED1 DDX55 ATAD2 LDLR KPTN GMPS NF1 UBN1 RNF20 SLTM KMT2A NKTR OBI1	1.86e-07	1327	172	23	32694731
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	IPO5 FLNB DMXL2 MYO1B NUP214 PRKRA GMPS NEFM VCAN RRP12 AK1 BOD1L1 OBI1 EPB41L1	2.14e-07	498	172	14	36634849
Pubmed	TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex.	IPO5 KIF13B SRSF11 GMPS TRIM33 HADHA MTREX EPB41L2 VCL	2.96e-07	179	172	9	36261009
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	IPO5 CACNA2D1 DTL BSDC1 NUP214 WASHC2A SPECC1 CLIP1 KIF24 KANSL3 FBXO38 TLN1 RRP12 FGA MCRS1 HADHA GPC5 FUS OBI1 VCL RBM17	3.08e-07	1155	172	21	20360068
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	MYO1B SRSF11 APOB CHD7 MED1 MDH2 DDX55 TTF1 CLIP1 PSMA8 PRKRA KANSL3 YTHDF1 RIF1 TLN1 PYCR1 KMT2A NKTR HADHA UQCRC2 MTREX EPB41L2 RBM17	3.30e-07	1371	172	23	36244648
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	RPLP0 MYCBP2 RBM10 CHD8 NUP214 MED1 DDX55 NF1 RRP12 RNF20 NKTR FUS MTREX	3.36e-07	440	172	13	34244565
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ATP6V1B2 DMXL2 RPLP0 MYCBP2 SYNM RTN3 NR3C1 MDH2 WASHC2A NDUFV3 R3HCC1L TLN1 RRP12 PYCR1 TACC1 HADHA UQCRC2 PEAK1 PPP6R2 FKBP5 EPB41L1 EPB41L2 VCL NPAT	3.58e-07	1487	172	24	33957083
Pubmed	The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin.	FLNB FLNC INPPL1	4.74e-07	4	172	3	11739414
Pubmed	Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle.	MYH1 MYH2 MYH4	4.74e-07	4	172	3	11029314
Pubmed	Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling.	MYH1 MYH2 MYH4	4.74e-07	4	172	3	18417546
Pubmed	Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity.	MYH1 MYH2 MYH4	4.74e-07	4	172	3	10388558
Pubmed	A human YAC transgene rescues craniofacial and neural tube development in PDGFRalpha knockout mice and uncovers a role for PDGFRalpha in prenatal lung growth.	MYH1 MYH2 MYH4	4.74e-07	4	172	3	11023856
Pubmed	RIM-BP3 is a manchette-associated protein essential for spermiogenesis.	RIMBP3 RIMBP3C RIMBP3B	4.74e-07	4	172	3	19091768
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	DOCK1 MYO10 RBM10 SRSF11 CHD7 KIF24 RNF220 RIF1 BBX TACC1 PLCB4 PEAK1 EPB41L1 EPB41L2	5.16e-07	536	172	14	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	DOCK1 MYO10 RBM10 SRSF11 CHD7 KIF24 RNF220 RIF1 BBX TACC1 PLCB4 PEAK1 EPB41L1 EPB41L2	5.39e-07	538	172	14	10512203
Pubmed	Myopathy associated LDB3 mutation causes Z-disc disassembly and protein aggregation through PKCα and TSC2-mTOR downregulation.	MYH1 MYH2 FLNC MYH4	5.56e-07	14	172	4	33742095
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	IPO5 FLNB ATP6V1B2 RPLP0 MYO7A MYO1B INTS8 GMPS NF1 TLN1 SLTM PYCR1 HADHA KIF5C UQCRC2 PPP6R2 VCL	5.70e-07	803	172	17	36517590
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	KIF13B MYO10 SRSF11 CHD8 CHD7 YTHDF1 TLN1 SLTM MTREX	6.63e-07	197	172	9	20811636
Pubmed	Human transcription factor protein interaction networks.	NCOA3 RBM10 CUL9 MYO1B CHD8 CHD7 NUP214 WASHC2A KANSL3 YTHDF1 TRIM33 RIF1 FAT1 BBX UBN1 RRP12 KMT2A MCRS1 HADHA QSER1 UQCRC2 VCL NPAT	6.75e-07	1429	172	23	35140242
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	IPO5 RBM10 CHD8 CHD7 MED1 NSD3 RIF1 RRP12 HLTF KMT2A HADHA EPB41L2	7.03e-07	394	172	12	27248496
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	MON2 MYCBP2 DTL RNF213 CHD7 NUP214 WASHC2A HMCES ERLEC1 YTHDF1 GUCY1B1 BOD1L1 TACC1 QSER1 FKBP5 VCL	8.37e-07	733	172	16	34672954
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	MYH1 FLNB MYH4 MYO7A MUC19 RNF213 MAGI3 ERLEC1 GMPS ESRP2 SLC38A10 R3HCC1L TLN1 BOD1L1 HADHA EPB41L2	8.83e-07	736	172	16	29676528
Pubmed	A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance.	MYH1 MYH2 MYH4 MYH7B	1.00e-06	16	172	4	19922871
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	FOXM1 IPO5 MUC19 CHD8 TRIM33 BBX RRP12 KMT2A FUS MTREX NPAT	1.12e-06	339	172	11	30415952
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	MYH1 MYH2 FLNB FLNC MYH4 RPLP0 RPLP0P6 MUC16 RNF213 PSMA8 GMPS YTHDF1 NEFM TLN1 HADHA FUS ALDH1A3	1.13e-06	844	172	17	25963833
Pubmed	NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler.	CHD8 NSD3 BOD1L1	1.18e-06	5	172	3	26626481
Pubmed	Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro.	MYH1 MYH2 MYH4	1.18e-06	5	172	3	3829126
Pubmed	Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development.	MYH1 MYH2 MYH4	1.18e-06	5	172	3	12919077
Pubmed	Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections.	MYH1 MYH2 MYH4	1.18e-06	5	172	3	30737693
Pubmed	Sequential accumulation of mRNAs encoding different myosin heavy chain isoforms during skeletal muscle development in vivo detected with a recombinant plasmid identified as coding for an adult fast myosin heavy chain from mouse skeletal muscle.	MYH1 MYH2 MYH4	1.18e-06	5	172	3	6196357
Pubmed	Structure and evolution of RIM-BP genes: identification of a novel family member.	RIMBP3 RIMBP3C RIMBP3B	1.18e-06	5	172	3	17855024
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	FLNB RPLP0 RBM10 MYO1B SRSF11 DDX55 ATAD2 INTS8 NSD3 YTHDF1 RIF1 RRP12 SLTM KMT2A FUS MTREX RBM17	1.18e-06	847	172	17	35850772
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	MON2 ATP6V1B2 MYCBP2 RNF213 MYO1B NSD3 GMPS FBXO38 RIF1 MTM1 RRP12 SLTM PYCR1 HADHA UQCRC2 PEAK1 PPP6R2 FKBP5 EPB41L1	1.24e-06	1049	172	19	27880917
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	FLNB FLNC NUP214 ATAD2 WASHC2A TLN1 OBI1 EPB41L2 RBM17	1.37e-06	215	172	9	35973513
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	FOXM1 FLNC KIF27 CUL9 NR3C1 FOXA3 TTF1 KANSL3 ESRP2 NEFM TRIM33 RIF1 BBX MCRS1 QSER1 OBI1 NOVA1	1.38e-06	857	172	17	25609649
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ATP6V1B2 CHD8 CHD7 MED1 DDX55 ATAD2 TTF1 SPECC1 INTS8 NSD3 TRIM33 RIF1 BBX TLN1 RRP12 HLTF KMT2A MCRS1 UQCRC2 MTREX EPB41L1 IPMK EPB41L2	1.49e-06	1497	172	23	31527615
Pubmed	Network organization of the human autophagy system.	DOCK1 IPO5 MYH2 FLNC MYH4 GMPS NEFM RIF1 XIRP2 MTM1 HADHA FKBP5	2.06e-06	437	172	12	20562859
Pubmed	Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance.	FOXM1 FLNB DTL SRSF11 CLIP1 TLN1 TACC1 EPB41L2 VCL	2.07e-06	226	172	9	31452512
Pubmed	C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways.	IPO5 RBM10 WDR26 RIF1 TLN1 HADHA OBI1	2.25e-06	119	172	7	35776542
Pubmed	Distinct myogenic programs of embryonic and fetal mouse muscle cells: expression of the perinatal myosin heavy chain isoform in vitro.	MYH1 MYH2 MYH4	2.35e-06	6	172	3	1728586
Pubmed	A hypoplastic model of skeletal muscle development displaying reduced foetal myoblast cell numbers, increased oxidative myofibres and improved specific tension capacity.	MYH1 MYH2 MYH4	2.35e-06	6	172	3	20417199
Pubmed	Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved.	MYH1 MYH2 MYH4	2.35e-06	6	172	3	10077619
Pubmed	A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre.	MYH1 MYH2 MYH4	2.35e-06	6	172	3	17559643
Pubmed	Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development.	MYH1 MYH2 MYH4	2.35e-06	6	172	3	10588881
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NCOA3 MYCBP2 RBM10 CHD8 CHD7 MED1 DDX55 GMPS KANSL3 TRIM33 TLN1 HLTF KMT2A HADHA QSER1 FUS MTREX FKBP5 RBM17	2.58e-06	1103	172	19	34189442
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	NCOA3 RBM10 DNAH7 YTHDF1 RIF1 BBX XIRP2 MAST1 KIF5A	2.65e-06	233	172	9	37704626
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	DOCK1 IPO5 FLNB RPLP0 MAGI3 MYO1B NUP214 GMPS TLN1 BOD1L1 HADHA PEAK1 EPB41L1 EPB41L2 VCL	2.69e-06	708	172	15	39231216
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	EFCAB5 FLNB RPLP0 MYO7B MYO1B GMPS FBXO38 MTREX KIF13A	2.75e-06	234	172	9	36243803
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	MYH1 MYH2 ABL1 MARK1 INPPL1 MYO1B ANKRD36C SPECC1 WDR26 NDUFV3 NF1 TLN1 KMT2A NKTR ANKRD36 PPP6R2 IPMK	3.09e-06	910	172	17	36736316
Pubmed	A novel functional role for MMSET in RNA processing based on the link between the REIIBP isoform and its interaction with the SMN complex.	RPLP0 MYCBP2 RBM10 MTREX	3.24e-06	21	172	4	24923560
Pubmed	HOXA5 plays tissue-specific roles in the developing respiratory system.	MYH1 MYH2 MYH4 PLIN2 NEFM	3.25e-06	46	172	5	28827394
Pubmed	Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.	IPO5 KIF13B RPLP0 MYO10 RBM10 SRSF11 MED1 MDH2 KIF24 NDUFV3 PRKRA YTHDF1 RNF20 HFM1 RBM17	3.47e-06	723	172	15	34133714
Pubmed	MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1.	IPO5 RPLP0 MYO1B MDH2 GMPS HADHA ALDH1A3 VCL	3.74e-06	182	172	8	30711629
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	IPO5 FLNB NUP214 WDR26 GMPS YTHDF1 TRIM33 RIF1 TLN1 PYCR1 HADHA FUS MTREX EPB41L2	3.93e-06	638	172	14	33239621
Pubmed	Comparative interactome analysis of α-arrestin families in human and Drosophila.	MON2 CACNA2D1 ATP6V1B2 FLNC CUL9 MYO1B NF1 BOD1L1 HADHA RBM17	4.00e-06	313	172	10	38270169
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	IPO5 ATP6V1B2 RPLP0 INPPL1 MYO1B SRSF11 NUP214 MED1 MDH2 SPECC1 PRKRA GMPS TLN1 HADHA FUS MTREX PPP6R2 FKBP5 VCL RBM17	4.04e-06	1247	172	20	27684187
Pubmed	Chromatin remodeler CHD7 is critical for cochlear morphogenesis and neurosensory patterning.	MYO7A CHD7 NEFM	4.10e-06	7	172	3	34004180
Pubmed	Tails of unconventional myosins.	MYO7A MYO7B MYO10	4.10e-06	7	172	3	11212352
Pubmed	A fast Myosin super enhancer dictates muscle fiber phenotype through competitive interactions with Myosin genes.	MYH1 MYH2 MYH4	4.10e-06	7	172	3	35210422
Pubmed	ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism.	MYH1 MYH2 MYH4	4.10e-06	7	172	3	29758057
Interaction	SIRT7 interactions	IPO5 FLNB FLNC RPLP0 MYCBP2 CUL9 MYO1B CHD8 CHD7 NUP214 ATAD2 TTF1 PRKRA GMPS NEFM RIF1 NF1 TLN1 RRP12 SLTM KMT2A HADHA UQCRC2 FUS MTREX EPB41L2 VCL	1.75e-10	744	171	27	int:SIRT7
Interaction	SLFN11 interactions	MYH2 FLNB SYNM MYH7B RBM10 RNF213 NUP214 NR3C1 MDH2 DDX55 LDLR TRIM33 RIF1 RRP12 HFM1 VCL	1.41e-07	376	171	16	int:SLFN11
Interaction	YWHAH interactions	KIF13B NCOA3 ABL1 MYCBP2 MARK1 INPPL1 DTL MAGI3 NR3C1 MED1 SPECC1 WDR26 DNAH7 NSD3 NF1 MTM1 MAST1 KMT2A CC2D2A BOD1L1 NKTR KIF5A KIF5C PEAK1 MTREX EPB41L1 EPB41L2 VCL	1.83e-07	1102	171	28	int:YWHAH
Interaction	SMC5 interactions	MYH1 MYH4 RPLP0 RPLP0P6 RBM10 SRSF11 CHD8 CHD7 NUP214 MED1 NSD3 NDUFV3 YTHDF1 TRIM33 RIF1 BBX UBN1 SLTM KMT2A BOD1L1 QSER1 UQCRC2 FUS RBM17 NPAT	1.21e-06	1000	171	25	int:SMC5
Interaction	H3C3 interactions	IPO5 CHD8 CHD7 MED1 DDX55 ATAD2 NSD3 FBXO38 RNF220 RIF1 BBX HLTF KMT2A BOD1L1 QSER1 NPAT	5.18e-06	495	171	16	int:H3C3
Interaction	KCTD13 interactions	IPO5 FLNB CACNA2D1 ATP6V1B2 FLNC DMXL2 RPLP0 MYO7A MARK1 RAPGEF4 RTN3 MDH2 SPECC1 PRKRA NEFM NF1 VCAN TLN1 FGA MAST1 KMT2A HADHA KIF5C UQCRC2 PEAK1 PPP6R2 EPB41L1 EPB41L2 VCL	6.15e-06	1394	171	29	int:KCTD13
Interaction	NUP43 interactions	MUC19 CHD8 NUP214 DDX55 ATAD2 TTF1 NSD3 KANSL3 RNF220 RIF1 BBX HLTF KMT2A BOD1L1 NKTR FUS PPP6R2 NPAT	6.46e-06	625	171	18	int:NUP43
Interaction	MEN1 interactions	KIF13B RPLP0 RBM10 RNF213 MYO1B CHD8 MED1 DDX55 ATAD2 INTS8 NSD3 KANSL3 YTHDF1 RIF1 RRP12 RNF20 SLTM KMT2A MCRS1 BOD1L1 QSER1 FUS MTREX RBM17	6.64e-06	1029	171	24	int:MEN1
Interaction	ASB7 interactions	KIF13B FGA KMT2A KIF13A VCL NPAT	7.81e-06	56	171	6	int:ASB7
Interaction	YWHAQ interactions	KIF13B NCOA3 MYH2 ABL1 RPLP0 MYCBP2 MARK1 DTL MED1 SPECC1 DNAH7 NF1 TLN1 RNF20 FGA KMT2A HADHA KIF5A KIF5C FUS PEAK1 MTREX EPB41L1 EPB41L2 VCL	8.67e-06	1118	171	25	int:YWHAQ
Interaction	SOX2 interactions	IPO5 SEMG2 NCOA3 ATP6V1B2 RPLP0 MARK1 CUL9 EML2 MYO1B CHD8 CHD7 NUP214 MED1 MDH2 WASHC2A WDR26 PSMA8 PRKRA YTHDF1 TRIM33 RRP12 SLTM FGA KMT2A BOD1L1 HADHA QSER1 FUS MTREX	9.00e-06	1422	171	29	int:SOX2
Interaction	CIT interactions	IPO5 FLNB FLNC KIF27 RPLP0 RPLP0P6 RBM10 RNF213 MAGI3 MYO1B CHD8 APOB MED1 MDH2 SPECC1 NEFM RIF1 RRP12 HLTF PYCR1 CNPY3 KMT2A BOD1L1 NKTR HADHA UQCRC2 FUS MTREX RBM17	1.30e-05	1450	171	29	int:CIT
Interaction	TOP3B interactions	MON2 IPO5 SDSL FLNC ABL1 MYCBP2 MYO7A MYO10 INPPL1 CUL9 EML2 MYO1B CHD8 APOB NUP214 WASHC2A LDLR NSD3 KANSL3 YTHDF1 ESRP2 FAT1 SLC38A10 UBN1 TLN1 RRP12 PCNX1 HMGXB3 HADHA	1.68e-05	1470	171	29	int:TOP3B
Interaction	TERF2IP interactions	SRSF11 CHD8 CHD7 MED1 DDX55 NSD3 KANSL3 TRIM33 RIF1 BBX RNF20 KMT2A AK1 BOD1L1 QSER1 NPAT	2.00e-05	552	171	16	int:TERF2IP
Interaction	MEX3A interactions	IPO5 FLNB ABL1 MYO10 CHD8 PSMA8 LDLR FAT1 UBN1 TLN1 HMGXB3 TACC1 ZNF518B	2.54e-05	384	171	13	int:MEX3A
Interaction	MECP2 interactions	FLNC DMXL2 RELN RPLP0 MYCBP2 MARK1 RBM10 MYO1B SRSF11 CHD7 MED1 DDX55 INTS8 NSD3 PRKRA NEFM BBX VCAN RRP12 SLTM NKTR HADHA UQCRC2 FUS EPB41L2 RBM17	3.28e-05	1287	171	26	int:MECP2
Interaction	AR interactions	NCOA3 ABL1 MYCBP2 RPLP0P6 RBM10 INPPL1 RNF213 MYO1B CHD8 CHD7 NR3C1 MED1 GMPS KANSL3 TRIM33 RNF20 KMT2A MCRS1 QSER1 MTREX FKBP5 RBM17	3.59e-05	992	171	22	int:AR
Interaction	KCNA3 interactions	DOCK1 IPO5 FLNB RPLP0 MYH7B RNF213 MAGI3 MYO1B NUP214 SPECC1 CLIP1 GMPS TLN1 KMT2A BOD1L1 HADHA PEAK1 EPB41L1 EPB41L2 VCL	5.17e-05	871	171	20	int:KCNA3
Interaction	YAP1 interactions	IPO5 FLNB ABL1 RPLP0 RPLP0P6 RBM10 MYO1B CHD8 MED1 MDH2 NSD3 NEFM NF1 IGFBP7 TLN1 KMT2A BOD1L1 HADHA KIF5A UQCRC2 FUS EPB41L2 VCL	5.44e-05	1095	171	23	int:YAP1
Interaction	ASF1A interactions	CHD8 CHD7 NSD3 FBXO38 TRIM33 RIF1 UBN1 KMT2A QSER1 NPAT	5.48e-05	249	171	10	int:ASF1A
Interaction	DCAF15 interactions	FOXM1 FLNB DTL SRSF11 CLIP1 TRIM33 TLN1 TACC1 EPB41L2 VCL	6.69e-05	255	171	10	int:DCAF15
Interaction	H3-3A interactions	IPO5 CHD8 CHD7 MED1 DDX55 ATAD2 NSD3 FBXO38 RNF220 RIF1 BBX UBN1 HLTF KMT2A BOD1L1 QSER1 FUS NPAT	7.06e-05	749	171	18	int:H3-3A
Interaction	FOXP3 interactions	SEMG2 CHD8 NUP214 NR3C1 FOXA3 SPECC1 NSD3 GMPS ESRP2 RIF1 TLN1 SLTM NOVA1	8.47e-05	432	171	13	int:FOXP3
Interaction	SFN interactions	KIAA0408 IPO5 KIF13B ABL1 MYCBP2 MARK1 DTL NR3C1 SPECC1 WDR26 KMT2A PEAK1 MTREX KIF13A OBI1 EPB41L2 VCL	8.68e-05	692	171	17	int:SFN
Interaction	SHANK3 interactions	RAPGEF4 RTN3 MDH2 ZNF496 NEFM NF1 XIRP2 MCRS1 KIF5A KIF5C UQCRC2 PPP6R2 EPB41L1 RBM17	8.91e-05	496	171	14	int:SHANK3
Interaction	ACTC1 interactions	FLNB RPLP0 CUL9 MYO1B SRSF11 MED1 MDH2 WASHC2A KPTN RIF1 TLN1 RNF20 BOD1L1 HADHA FUS VCL RBM17	8.99e-05	694	171	17	int:ACTC1
Interaction	LATS1 interactions	MYH1 MYH2 MYH4 SLC26A2 RBM10 MAGI3 MYO1B ARMCX1 RIF1 XIRP2 SLTM FKBP5 RBM17	1.02e-04	440	171	13	int:LATS1
Interaction	SETD1A interactions	CHD8 KANSL3 PYCR1 KMT2A MCRS1 BOD1L1 EPB41L1 EPB41L2	1.04e-04	170	171	8	int:SETD1A
Interaction	ITGB3 interactions	IPO5 DOK1 FLNB FLNC MYO10 TLN1 FGA VCL	1.04e-04	170	171	8	int:ITGB3
Interaction	SYCE1 interactions	INPPL1 CLIP1 NEFM AKTIP RNF20 KIF5A KIF5C	1.06e-04	127	171	7	int:SYCE1
Interaction	DSCAM interactions	FLNB ATP6V1B2 RAPGEF4 CUL9 MAGI3 INTS8 NEFM KIF5A	1.08e-04	171	171	8	int:DSCAM
Interaction	WDR76 interactions	FLNB RBM10 CHD8 CHD7 ATAD2 WDR26 VCAN RRP12 HLTF HADHA FUS EPB41L2	1.09e-04	383	171	12	int:WDR76
Interaction	NUP62 interactions	IPO5 NUP214 NR3C1 SPECC1 CLIP1 NEFM TRIM33 RNF20 KIF5A KIF5C	1.17e-04	273	171	10	int:NUP62
Interaction	PML interactions	FOXM1 IPO5 FLNC RNF213 CHD8 NR3C1 MED1 ZNF496 HMCES KANSL3 TRIM33 NF1 UBN1 TLN1 RRP12 RNF20 SLTM CNPY3 KMT2A EPB41L2	1.32e-04	933	171	20	int:PML
Interaction	HSP90B1 interactions	DMXL2 MYO10 MYO1B APOB NR3C1 LDLR ERLEC1 ESRP2 RIF1 DNAH17 SLTM KMT2A HADHA KIF5A UQCRC2 FUS	1.38e-04	650	171	16	int:HSP90B1
Interaction	NUDC interactions	FLNB FLNC ANKRD36C MDH2 DNAH7 TLN1 WDR35 BOD1L1 PPP6R2 FKBP5 EPB41L2	1.49e-04	337	171	11	int:NUDC
Interaction	BIRC3 interactions	IPO5 FLNB KIF27 RPLP0 RTN3 MYO1B APOB NUP214 MDH2 ATAD2 RIF1 NF1 TLN1 RRP12 RNF20 SLTM PYCR1 CC2D2A HADHA UQCRC2 FUS PEAK1 MTREX EPB41L2 VCL	1.56e-04	1334	171	25	int:BIRC3
Interaction	NUP50 interactions	FLNB CHD7 NUP214 MED1 NSD3 TRIM33 CNPY3 KMT2A BOD1L1 EPB41L1 NPAT	1.65e-04	341	171	11	int:NUP50
Interaction	HSP90AB1 interactions	ATP6V1B2 DMXL2 RPLP0 MYCBP2 RPLP0P6 INPPL1 MAGI3 NR3C1 CLIP1 TLN1 RRP12 MAST1 KMT2A BOD1L1 HADHA UQCRC2 FUS PEAK1 FKBP5 EPB41L2	1.93e-04	960	171	20	int:HSP90AB1
Interaction	THRB interactions	NCOA3 CHD7 MED1 CLIP1 LDLR HADHA GPC5 UQCRC2	1.93e-04	186	171	8	int:THRB
Interaction	KRT222 interactions	NEFM TACC1 EPB41L1 EPB41L2	2.13e-04	35	171	4	int:KRT222
Interaction	MYO7B interactions	MYO7B HADHA	2.14e-04	3	171	2	int:MYO7B
Interaction	RNF123 interactions	MYH1 FLNB FLNC MYH4 MYO7A MUC19 RNF213 MAGI3 NR3C1 ERLEC1 GMPS ESRP2 SLC38A10 R3HCC1L TLN1 BOD1L1 HADHA EPB41L2	2.31e-04	824	171	18	int:RNF123
Interaction	NAA40 interactions	RPLP0 RBM10 MYO1B NUP214 NR3C1 MED1 MDH2 GMPS RIF1 ALDH1A2 R3HCC1L TLN1 RRP12 KMT2A BOD1L1 TACC1 PPP6R2 EPB41L2 VCL RBM17	2.46e-04	978	171	20	int:NAA40
Interaction	RAB11A interactions	MON2 KIF13B CACNA2D1 ATP6V1B2 DMXL2 MUC19 RTN3 NR3C1 WASHC2A SPECC1 NEFM RRP12 TACC1 PLCB4 HADHA PEAK1 KIF13A EPB41L1	2.53e-04	830	171	18	int:RAB11A
Interaction	ANKMY2 interactions	KANSL3 GUCY1B1 KIF5C MTREX FKBP5	2.62e-04	67	171	5	int:ANKMY2
Interaction	SIRT6 interactions	FLNB RPLP0 MYCBP2 RBM10 CHD8 NUP214 MED1 DDX55 FAT1 NF1 RRP12 RNF20 NKTR FUS MTREX	3.09e-04	628	171	15	int:SIRT6
Interaction	AMPD1 interactions	MYH2 NR3C1 XIRP2	3.10e-04	16	171	3	int:AMPD1
Interaction	BAP1 interactions	IPO5 FLNB FLNC RPLP0 MYCBP2 RBM10 MYO1B NR3C1 MDH2 WDR26 PRKRA GMPS NEFM FAT1 TLN1 RRP12 PYCR1 MCRS1 HADHA FUS OBI1 FKBP5 EPB41L2 VCL	3.12e-04	1314	171	24	int:BAP1
Cytoband	9q34.1	ABL1 NUP214 AK1	4.79e-05	19	172	3	9q34.1
GeneFamily	Kinesins\|Pleckstrin homology domain containing	KIF13B KIF27 KIF24 KIF5A KIF5C KIF13A	5.41e-07	46	119	6	622
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	MYO7A MYO7B MYO10 TLN1 EPB41L1 EPB41L2	8.98e-07	50	119	6	1293
GeneFamily	Myosin heavy chains	MYH1 MYH2 MYH4 MYH7B	2.30e-06	15	119	4	1098
GeneFamily	A-kinase anchoring proteins\|Myosins, class VII\|Deafness associated genes\|FERM domain containing	MYO7A MYO7B	4.30e-05	2	119	2	1102
GeneFamily	Erythrocyte membrane protein band 4.1\|FERM domain containing	EPB41L1 EPB41L2	2.56e-04	4	119	2	951
GeneFamily	Perilipins	PLIN4 PLIN2	4.24e-04	5	119	2	678
GeneFamily	Intermediate filaments Type IV	SYNM NEFM	6.33e-04	6	119	2	611
GeneFamily	X-linked mental retardation\|RNA helicases	HFM1 MTREX	2.27e-03	11	119	2	1168
GeneFamily	RNA binding motif containing	RBM10 SRSF11 ESRP2 SLTM FUS RBM17	2.87e-03	213	119	6	725
GeneFamily	CD molecules\|Type II classical cadherins	CDH22 CDH10	3.20e-03	13	119	2	1186
GeneFamily	Dyneins, axonemal	DNAH7 DNAH17	5.48e-03	17	119	2	536
GeneFamily	Cadherin related	CDHR2 FAT1	5.48e-03	17	119	2	24
GeneFamily	FKBP prolyl isomerases	FKBP2 FKBP5	6.14e-03	18	119	2	910
GeneFamily	Aldehyde dehydrogenases	ALDH1A2 ALDH1A3	6.83e-03	19	119	2	398
GeneFamily	Zinc fingers RANBP2-type \|RNA binding motif containing	RBM10 FUS	8.31e-03	21	119	2	89
GeneFamily	CD molecules\|Mucins	MUC19 MUC16	8.31e-03	21	119	2	648
GeneFamily	G-patch domain containing\|Minor histocompatibility antigens	RBM10 RBM17	9.11e-03	22	119	2	579
GeneFamily	Ring finger proteins	RNF213 TRIM33 RNF220 RNF20 HLTF OBI1	9.74e-03	275	119	6	58
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	DOCK1 NCOA3 FLNB DMXL2 MYCBP2 MYO10 TOGARAM1 MYO1B NR3C1 MED1 CLIP1 LDLR GMPS TRIM33 RIF1 FAT1 BBX HLTF PLCB4 KIF5C MTREX VCL NPAT	1.08e-08	856	172	23	M4500
Coexpression	MURARO_PANCREAS_BETA_CELL	NCOA3 CACNA2D1 ATP6V1B2 DMXL2 MYCBP2 SYNM MARK1 TOGARAM1 CHD7 NR3C1 CLIP1 PPP1R1A NEFM AKTIP BBX UBN1 HLTF PLCB4 KIF5C KIF13A FKBP5 EPB41L1	2.83e-07	946	172	22	M39169
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	IPO5 MYCBP2 MYO10 SRSF11 ATAD2 SPECC1 CLIP1 TRIM33 RIF1 BBX RNF20 HLTF NKTR QSER1 MTREX OBI1 RBM17	1.66e-06	656	172	17	M18979
Coexpression	GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN	MYO7B RBM10 RTN3 CCDC92 NR3C1 MDH2 KANSL3 DNAH17 VCL	6.79e-06	198	172	9	M3242
Coexpression	GSE42724_MEMORY_BCELL_VS_PLASMABLAST_DN	TOGARAM1 SPECC1 WDR26 PRKRA RIF1 NF1 HLTF TACC1 KIF13A	7.37e-06	200	172	9	M9791
Coexpression	TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING	DOCK1 NCOA3 RPLP0 MYCBP2 CES1 RTN3 NR3C1 MED1 NSD3 PLIN2 ALDH1A2 IGFBP7 CNPY3 TACC1 FUS FKBP2	1.25e-05	685	172	16	MM3782
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	NCOA3 FLNB MYCBP2 MYO10 MYO1B NR3C1 CLIP1 GMPS TRIM33 FAT1 BBX KIF5C MTREX	1.35e-05	466	172	13	M13522
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HPERIC	DOCK1 EFCAB5 SYNM RAPGEF4 RNF213 MYO1B NR3C1 SPECC1 IGFBP7 GUCY1B1 TLN1 TACC1 PEAK1 FKBP5 EPB41L1 EPB41L2 VCL	2.05e-05	795	172	17	M39050
Coexpression	LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES	CACNA2D1 RAPGEF4 TACC1 NKTR GPC5 PEAK1 FKBP5	3.48e-05	137	172	7	M39241
Coexpression	RAO_BOUND_BY_SALL4_ISOFORM_A	KIF27 CES1 SPECC1 FAT1 ALDH1A2 R3HCC1L XIRP2 PLCB4	4.46e-05	194	172	8	M2517
Coexpression	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	RELN SYNM NEFM CDH22 GPC5 KIF5C EPB41L1	4.58e-05	143	172	7	M1935
Coexpression	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	RELN SYNM NEFM CDH22 GPC5 KIF5C EPB41L1	4.58e-05	143	172	7	MM819
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	ATP6V1B2 MARK1 DTL CHD8 NR3C1 KIF24 RIF1 IGFBP7	4.63e-05	195	172	8	M1110
Coexpression	GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP	FOXM1 RUSC1 MUC16 KPTN KANSL3 ESRP2 GUCY1B1 QSER1	5.15e-05	198	172	8	M8041
Coexpression	GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_DN	MYO7B MYO10 ODAD4 WASHC2A BBX PLCB4 PEAK1 FKBP5	5.34e-05	199	172	8	M8093
Coexpression	GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP	IPO5 MYH1 DTL RUSC1 CHD8 R3HCC1L TLN1 VCL	5.53e-05	200	172	8	M7256
Coexpression	GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP	ABL1 RUSC1 MDH2 TTF1 ZNF623 DNAH7 GMPS CNPY3	5.53e-05	200	172	8	M5231
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	ABL1 RNF213 NUP214 SPECC1 NSD3 GMPS TRIM33 NF1 KMT2A FUS	5.79e-05	323	172	10	M9150
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	ATP6V1B2 MARK1 DTL CHD8 NR3C1 KIF24 RIF1 IGFBP7	7.04e-05	207	172	8	MM475
Coexpression	RAO_BOUND_BY_SALL4_ISOFORM_A	KIF27 CES1 SPECC1 FAT1 ALDH1A2 R3HCC1L XIRP2 PLCB4	7.79e-05	210	172	8	MM958
Coexpression	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	ATP6V1B2 RELN MYCBP2 MYO7A CDHR2 MYO10 PLIN2 PCNX1 HADHA	8.71e-05	274	172	9	M13014
Coexpression	THUM_SYSTOLIC_HEART_FAILURE_DN	MON2 PRKRA RIF1 BBX UBN1 TACC1 NKTR UQCRC2	1.33e-04	227	172	8	M18441
Coexpression	HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL	FOXM1 IPO5 DTL RUSC1 CHD7 ANKRD36C ATAD2 TTF1 HMCES LDLR GMPS RIF1 HLTF ANKRD36 FKBP5 EPB41L2 NPAT	1.58e-04	939	172	17	M45768
Coexpression	GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN	KIF13B SPECC1 WDR26 ESRP2 SLC38A10 FKBP5 VCL	1.63e-04	175	172	7	M8892
Coexpression	BILD_CTNNB1_ONCOGENIC_SIGNATURE	NCOA3 FLNB NR3C1 VCAN BOD1L1	1.75e-04	79	172	5	M7102
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	MYO10 CHD7 ATAD2 TRIM33 RIF1 NF1 TLN1	1.93e-04	180	172	7	M8239
Coexpression	RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN	DMXL2 CES1 NUP214 PLIN2 IGFBP7 VCAN CNPY3 NKTR HADHA	2.78e-04	320	172	9	M8582
Coexpression	HUMMERICH_BENIGN_SKIN_TUMOR_DN	MYH1 MYH2 MYH4	2.92e-04	20	172	3	M1123
Coexpression	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	MON2 FLNB CACNA2D1 BSDC1 RNF213 SRSF11 CCDC92 CLIP1 ABCA8 SLC38A10 NF1 BBX NKTR PPP6R2 FKBP5	2.95e-04	807	172	15	M16651
Coexpression	GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_DN	NUP214 FOXA3 PLIN2 SLC38A10 IGFBP7 FKBP5 VCL	2.96e-04	193	172	7	M9717
Coexpression	GSE3982_MAST_CELL_VS_MAC_DN	SRSF11 MED1 HMCES ARMCX1 PIK3C2G QSER1 FKBP5	3.15e-04	195	172	7	M5431
Coexpression	ERBB2_UP.V1_DN	FLNB SLC26A2 DTL ARMCX1 RIF1 KIF5C SLC6A14	3.35e-04	197	172	7	M2635
Coexpression	HUMMERICH_BENIGN_SKIN_TUMOR_DN	MYH1 MYH2 MYH4	3.39e-04	21	172	3	MM1102
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	MON2 SDSL FLNB CACNA2D1 RELN MARK1 SLC26A2 INPPL1 RUSC1 SPECC1 IGFBP7 WDR35 AK1 PCNX1 KIF13A CDH10 EPB41L1 EPB41L2	3.53e-04	1102	172	18	M2369
Coexpression	GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_UP	IPO5 MYO1B NR3C1 RIF1 RRP12 UQCRC2 FUS	3.56e-04	199	172	7	M8863
Coexpression	GSE4142_NAIVE_VS_GC_BCELL_UP	MAGI3 TACC1 QSER1 ANKRD45 EPB41L2 VCL NOVA1	3.56e-04	199	172	7	M6375
Coexpression	HALLMARK_MITOTIC_SPINDLE	FLNB ABL1 CLIP1 KPTN NF1 EPB41L2 VCL	3.56e-04	199	172	7	M5893
Coexpression	GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN	MYH1 HMCES FBXO38 RRP12 MCRS1 GPC5 FKBP5	3.56e-04	199	172	7	M5366
Coexpression	GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_DN	CHD7 PPP1R1A YTHDF1 FAT1 DNAH17 PPP6R2 NOVA1	3.56e-04	199	172	7	M2921
Coexpression	GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP	CHD8 DNAH7 PLIN2 GMPS TRIM33 VCAN KIF5C	3.56e-04	199	172	7	M5235
Coexpression	GSE39556_CD8A_DC_VS_NK_CELL_UP	FOXM1 DMXL2 NR3C1 GMPS IGFBP7 HLTF VCL	3.67e-04	200	172	7	M9406
Coexpression	GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_DN	FLNB ATP6V1B2 MYO10 CHD7 KANSL3 ALDH1A2 BBX	3.67e-04	200	172	7	M9344
Coexpression	GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP	CUL9 NR3C1 MED1 CLIP1 ARMCX1 PTGR3 RNF220	3.67e-04	200	172	7	M4584
Coexpression	GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN	EML2 WASHC2A TTF1 KANSL3 UBN1 RIMBP3C TACC1	3.67e-04	200	172	7	M322
Coexpression	GSE43955_1H_VS_20H_ACT_CD4_TCELL_DN	FLNB MYH4 TTF1 PLIN2 FGA KMT2A FKBP5	3.67e-04	200	172	7	M9662
Coexpression	GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN	FLNB MYH4 RBKS CHD8 PLIN2 AK1 FKBP5	3.67e-04	200	172	7	M9680
Coexpression	GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP	MYCBP2 BSDC1 CHD7 MED1 CDH22 DNAH17 BOD1L1	3.67e-04	200	172	7	M4884
Coexpression	GSE17721_CTRL_VS_POLYIC_4H_BMDC_DN	MYH1 FLNB NR3C1 KPTN VCAN PCNX1 VCL	3.67e-04	200	172	7	M3714
Coexpression	GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP	DTL NSD3 RIF1 RNF20 WDR35 BOD1L1 IPMK	3.67e-04	200	172	7	M7525
Coexpression	GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_DN	NCOA3 MYO10 MARK1 CUL9 DNAH17 PPP6R2 SLC6A14	3.67e-04	200	172	7	M7799
Coexpression	GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP	DOK1 KIF13B RUSC1 CHD8 ZNF623 PLIN2 NPAT	3.67e-04	200	172	7	M7640
Coexpression	GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_DN	CACNA2D1 ATP6V1B2 ABL1 CLIP1 RNF220 PIK3C2G ALDH1A3	3.67e-04	200	172	7	M9067
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	RELN MYCBP2 MYO7A MARK1 MUC19 RUSC1 MAGI3 CLIP1 CDH22 VCAN MAST1 BOD1L1 PLCB4 ANKRD36 KIF5C KIF13A EPB41L1 NOVA1	3.69e-04	1106	172	18	M39071
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_200	FLNC MUC16 NEFM ALDH1A2 GUCY1B1 VCAN CDH10	2.37e-06	76	168	7	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k3_200
CoexpressionAtlas	DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000	DOCK1 CACNA2D1 MYO10 NUP214 ATAD2 INTS8 RIF1 VCAN KIF5C	2.51e-06	146	168	9	gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000	DOCK1 CACNA2D1 MYCBP2 MYO10 MARK1 NUP214 WDR26 NSD3 GUCY1B1 VCAN ZNF518B KIF5C	7.51e-06	312	168	12	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	CACNA2D1 DMXL2 MYO10 RTN3 CHD7 CLIP1 LDLR ERLEC1 NEFM RIF1 R3HCC1L TRAM1L1 IGFBP7 SLTM CC2D2A BOD1L1 NKTR KIF5C IPMK NOVA1	9.78e-06	831	168	20	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_200	FLNC MUC16 NEFM ALDH1A2 CDH10	1.04e-05	37	168	5	gudmap_dev gonad_e11.5_M_GonMes_Sma_k1_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	CACNA2D1 RTN3 SRSF11 CHD7 CLIP1 PRKRA TRIM33 RIF1 BBX IGFBP7 RNF20 SLTM BOD1L1 KIF5C QSER1 MTREX EPB41L1	1.09e-05	629	168	17	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	DOCK1 CACNA2D1 MYCBP2 MYO10 RAPGEF4 NUP214 MED1 WDR26 CLIP1 BBX VCAN ZNF518B KIF13A	1.26e-05	385	168	13	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#2_top-relative-expression-ranked_200	FLNC MUC16 NEFM ALDH1A2 CDH10	1.74e-05	41	168	5	gudmap_dev gonad_e11.5_F_GonMes_Sma_k2_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	DOCK1 CACNA2D1 MYCBP2 MYO10 MARK1 NUP214 WDR26 NSD3 ESRP2 NEFM ALDH1A2 GUCY1B1 VCAN PLCB4 ZNF518B HADHA KIF5C CDH10 VCL	2.21e-05	806	168	19	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	RTN3 CHD7 CLIP1 NEFM RIF1 IGFBP7 SLTM KIF5C NOVA1	2.30e-05	192	168	9	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	DOCK1 CACNA2D1 MYCBP2 MYO10 MARK1 RAPGEF4 NUP214 MED1 WDR26 CLIP1 NEFM BBX VCAN PLCB4 ZNF518B KIF5A KIF5C KIF13A CDH10	2.70e-05	818	168	19	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000	KIAA0408 CACNA2D1 CHD7 NEFM TRAM1L1 PLCB4 KIF5C CDH10 NOVA1	3.43e-05	202	168	9	gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k3_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_500	DOCK1 CACNA2D1 NUP214 INTS8 VCAN KIF5C	3.60e-05	78	168	6	gudmap_developingKidney_e15.5_Cap mesenchyme_500_k5
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_200	FLNC MUC16 RNF213 NEFM ALDH1A2 GUCY1B1 VCAN CDH10	4.57e-05	162	168	8	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_200
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000	DMXL2 SYNM RNF213 SRSF11 CHD8 NR3C1 DNAH7 PSMA8 NSD3 GMPS RIF1 BBX UBN1 MTM1 NKTR FUS PEAK1 EPB41L2	4.68e-05	778	168	18	gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000	MON2 DOCK1 SDSL CACNA2D1 MYO10 MYO1B CHD7 NUP214 ATAD2 INTS8 NSD3 PPP1R1A RIF1 ALDH1A2 VCAN HLTF KIF5C FUS	4.76e-05	779	168	18	gudmap_developingKidney_e15.5_Cap mesenchyme_1000
CoexpressionAtlas	dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500	KIAA0408 CHD7 NEFM TRAM1L1 PLCB4 KIF5C NOVA1	7.62e-05	129	168	7	gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k2_500
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000	NCOA3 SRSF11 CHD8 NR3C1 NSD3 GMPS NKTR FUS EPB41L2	7.90e-05	225	168	9	gudmap_developingGonad_e14.5_ ovary_1000_k3
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000	CACNA2D1 FLNC ABL1 MUC16 NEFM ALDH1A2 GUCY1B1 VCAN WDR35 ZNF518B CDH10	8.06e-05	337	168	11	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000	KIAA0408 NCOA3 ATP6V1B2 SRSF11 CHD8 CHD7 NSD3 GMPS NEFM RIF1 ALDH1A2 TRAM1L1 NKTR KIF5C FUS OBI1 CDH10 EPB41L2	8.47e-05	815	168	18	gudmap_developingGonad_e11.5_ovary + mesonephros_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5	CACNA2D1 MYO10 CHD7 NEFM RIF1 SLTM KIF5C IPMK NOVA1	9.98e-05	232	168	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5
CoexpressionAtlas	dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000	ATP6V1B2 MYO10 INPPL1 RAPGEF4 RNF213 CHD7 DNAH7 ABCA8 TRIM33 FAT1 ALDH1A2 VCAN TACC1 HADHA CDH10 FKBP5 EPB41L1 SLC6A14	1.18e-04	837	168	18	gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	CACNA2D1 SRSF11 CHD7 SLTM BOD1L1 KIF5C QSER1 RBM17	1.20e-04	186	168	8	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_100	NEFM ALDH1A2 VCAN CDH10	1.83e-04	36	168	4	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_100
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500	SRSF11 CHD8 GMPS NKTR FUS EPB41L2	2.10e-04	107	168	6	gudmap_developingGonad_e14.5_ epididymis_500_k2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	DOCK1 CACNA2D1 MYCBP2 MYO10 MARK1 RAPGEF4 NUP214 ESRP2 NEFM ALDH1A2 GUCY1B1 VCAN ZNF518B HADHA KIF5C CDH10 NOVA1	2.32e-04	806	168	17	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500	CACNA2D1 FLNC MUC16 NEFM ALDH1A2 GUCY1B1 VCAN CDH10	2.50e-04	207	168	8	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000	DOCK1 CACNA2D1 MYCBP2 MARK1 RAPGEF4 SRSF11 NEFM RIF1 TRAM1L1 VCAN PLCB4 ZNF518B KIF5A KIF5C ALDH1A3 CDH10 NOVA1	2.75e-04	818	168	17	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_100	RNF213 NEFM ALDH1A2 VCAN CDH10	2.84e-04	73	168	5	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_100
CoexpressionAtlas	DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_1000	ATP6V1B2 MYO7A SYNM MYO10 CHD8 GMPS RIF1 SLC38A10 BBX UBN1 GUCY1B1 RRP12 HADHA FUS FKBP5 EPB41L2 VCL	2.91e-04	822	168	17	gudmap_developingGonad_e14.5_ testes_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000	CACNA2D1 FLNC ABL1 DTL MUC16 RNF213 CHD7 DNAH7 ABCA8 NEFM ALDH1A2 GUCY1B1 VCAN WDR35 ZNF518B CDH10 FKBP5	3.12e-04	827	168	17	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000	DOCK1 NCOA3 CACNA2D1 MYO10 SRSF11 NUP214 INTS8 CLIP1 VCAN ZNF518B FUS	3.34e-04	397	168	11	gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#2_top-relative-expression-ranked_200	FLNC MUC16 NEFM ALDH1A2	3.35e-04	42	168	4	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k2_200
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000	NCOA3 SRSF11 CHD8 NR3C1 NSD3 GMPS NKTR FUS EPB41L2	3.54e-04	275	168	9	gudmap_developingGonad_e14.5_ epididymis_1000_k3
CoexpressionAtlas	dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000	KIAA0408 RAPGEF4 CHD7 NEFM TRAM1L1 PLCB4 KIF5A KIF5C NOVA1	3.83e-04	278	168	9	gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k4_1000
CoexpressionAtlas	dev gonad_e13.5_M_SertoliCell_Sox9_k-means-cluster#2_top-relative-expression-ranked_500	MYO7A SYNM PRKRA FAT1 MTM1 TACC1 FKBP5	3.89e-04	168	168	7	gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_k2_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	CACNA2D1 FLNC MYO10 INPPL1 MUC16 RNF213 ATAD2 NEFM FAT1 ALDH1A2 IGFBP7 GUCY1B1 VCAN FKBP5 EPB41L2 SLC6A14	4.07e-04	768	168	16	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_100	CHD8 GMPS NEFM FUS CDH10	4.10e-04	79	168	5	gudmap_developingGonad_e11.5_ovary + mesonephros_100
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000	MYH2 DMXL2 SYNM MYO10 RNF213 SRSF11 CHD8 NR3C1 PSMA8 GMPS RIF1 BBX MTM1 NKTR FUS EPB41L2	4.19e-04	770	168	16	gudmap_developingGonad_P2_ovary_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	FOXM1 CACNA2D1 FLNC MARK1 MUC16 RNF213 ARMCX1 ALDH1A2 IGFBP7 GUCY1B1 VCAN CC2D2A QSER1 PEAK1 FKBP5 EPB41L2	4.62e-04	777	168	16	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	kidney_adult_Mesangium_Meis_k-means-cluster#2_top-relative-expression-ranked_1000	CACNA2D1 MYO10 MARK1 MYO1B SPECC1 FAT1 GUCY1B1 TACC1 EPB41L2 VCL	4.69e-04	348	168	10	gudmap_kidney_adult_Mesangium_Meis_k2_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_100	RNF213 NEFM ALDH1A2 VCAN CDH10	4.88e-04	82	168	5	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_100
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	MYO10 DTL SRSF11 CHD7 ATAD2 TTF1 CLIP1 KIF24 PPP1R1A GMPS NEFM RIF1 AKTIP RNF20 SLTM BOD1L1 ZNF518B GPC5 KIF5C QSER1 ANKRD45 MTREX OBI1 RBM17	5.12e-04	1459	168	24	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_200	FLNC MUC16 RNF213 NEFM ALDH1A2 VCAN CDH10	5.14e-04	176	168	7	gudmap_dev gonad_e11.5_M_GonMes_Sma_200
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500	CACNA2D1 FLNC DTL MUC16 RNF213 NEFM ALDH1A2 GUCY1B1 VCAN CDH10 FKBP5	5.14e-04	418	168	11	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_200	RNF213 FAT1 ALDH1A2 VCAN TACC1 FKBP5 SLC6A14	5.32e-04	177	168	7	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_200
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000	CACNA2D1 FLNC MUC16 NEFM ALDH1A2 GUCY1B1 VCAN WDR35 QSER1 CDH10	5.36e-04	354	168	10	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000	FLNC KIF27 MUC16 RNF213 DNAH7 ABCA8 PLIN2 NEFM ALDH1A2 VCAN HADHA PEAK1 ANKRD45 CDH10 FKBP5 EPB41L1	6.08e-04	797	168	16	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500	CACNA2D1 FLNC MUC16 RNF213 FAT1 ALDH1A2 IGFBP7 GUCY1B1 VCAN FKBP5	6.64e-04	364	168	10	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	NCOA3 MYO10 RNF213 SRSF11 CHD8 NSD3 GMPS NEFM RIF1 ALDH1A2 BBX TACC1 NKTR FUS CDH10 EPB41L2	6.85e-04	806	168	16	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_1000	CHD7 PLIN2 ALDH1A2 PLCB4 PEAK1	7.09e-04	89	168	5	gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k3_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000	DOCK1 CACNA2D1 MYCBP2 MYO10 MARK1 RAPGEF4 NUP214 GUCY1B1 VCAN ZNF518B	7.37e-04	369	168	10	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_100	NEFM ALDH1A2 CDH10	7.67e-04	23	168	3	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_100
CoexpressionAtlas	DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000	DOCK1 NCOA3 MYCBP2 RAPGEF4 NUP214	7.85e-04	91	168	5	DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	CACNA2D1 SYNM MYO10 SRSF11 CHD8 CHD7 NR3C1 SPECC1 NEFM RIF1 AKTIP IGFBP7 SLTM MAST1 KIF5C PEAK1 IPMK NOVA1	8.11e-04	983	168	18	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	MYO10 DTL SRSF11 ATAD2 TTF1 CLIP1 KIF24 PPP1R1A GMPS RIF1 AKTIP RNF20 SLTM BOD1L1 ZNF518B GPC5 QSER1 ANKRD45 MTREX OBI1 RBM17	9.65e-04	1257	168	21	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 RELN MYCBP2 MYO10 RAPGEF4 LDLR PPP1R1A RIF1 SLC38A10 KMT2A BOD1L1 NKTR	1.61e-11	195	172	12	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	MON2 RNF213 SRSF11 ANKRD36C LDLR RRP12 KMT2A PCNX1 NKTR ANKRD36 FUS	2.48e-10	192	172	11	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 RELN MYCBP2 RAPGEF4 LDLR PPP1R1A RIF1 SLC38A10 KMT2A BOD1L1 NKTR	2.93e-10	195	172	11	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	MON2 RNF213 ANKRD36C LDLR NF1 KMT2A PCNX1 NKTR ANKRD36 FUS	3.40e-09	188	172	10	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0408 MYH1 RELN MYO7B APOB FAT1 XIRP2 PIK3C2G KIF5A	4.35e-08	184	172	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0408 MYH1 RELN MYO7B APOB FAT1 XIRP2 PIK3C2G KIF5A	4.35e-08	184	172	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0408 MYH1 RELN MYO7B APOB FAT1 XIRP2 PIK3C2G KIF5A	4.35e-08	184	172	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA2D1 SYNM MYO10 MARK1 MYO1B GUCY1B1 TACC1 PLCB4 EPB41L2	5.24e-08	188	172	9	ee151792c7ac9afe820f1a281c6dab383799f358
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	MON2 KIF13B NCOA3 MYCBP2 RNF213 ANKRD36C LDLR NKTR FUS	6.00e-08	191	172	9	9454f642c3621370fa23640b631301346b300950
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	DOCK1 MYO1B SPECC1 ABCA8 IGFBP7 VCAN TACC1 EPB41L2 NOVA1	6.27e-08	192	172	9	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	SRSF11 ANKRD36C DDX55 TTF1 SLTM BOD1L1 NKTR ANKRD36 FKBP2	7.82e-08	197	172	9	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FLNB DTL RAPGEF4 RNF213 CHD7 KMT2A PLCB4 NKTR ZNF518B	8.89e-08	200	172	9	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	RNF213 APOB ANKRD36C LDLR PCNX1 NKTR ANKRD36 FUS	3.50e-07	171	172	8	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLIN4 FLNC RELN MYO7A SYNM CDH22 IGFBP7 EPB41L2	3.83e-07	173	172	8	7dc988fc0ba29990567bf1bcdeb3faeeee507eb1
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA2D1 SYNM MYO10 MARK1 MYO1B GUCY1B1 PLCB4 EPB41L2	4.75e-07	178	172	8	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 MYH2 PPP1R1A CDH22 XIRP2 PYCR1 AK1 SLC6A14	4.96e-07	179	172	8	4135f9e8cd8494cbc189e5210dded84659643fb8
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	MON2 DMXL2 MYCBP2 DTL RNF213 LDLR MTM1 FUS	6.37e-07	185	172	8	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNM MYO10 MARK1 MYO1B FAT1 GUCY1B1 TACC1 EPB41L2	6.63e-07	186	172	8	888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCell	CV-Moderate-7\|CV / Virus stimulation, Condition and Cluster	MON2 DMXL2 MYCBP2 DTL RNF213 ANKRD36C MTM1 FUS	6.63e-07	186	172	8	8571956890fc9894d766ba294a28e376b4aba428
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CACNA2D1 MYO10 MYO1B LDLR ABCA8 GUCY1B1 VCAN EPB41L2	6.91e-07	187	172	8	a9316e2818217ec5feae9cf8816f7249803caee6
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SYNM MYO10 MARK1 MYO1B FAT1 IGFBP7 GUCY1B1 TACC1	7.79e-07	190	172	8	4eb92aef1ee868f4537483d19014d947b7684612
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SYNM MYO10 MARK1 MYO1B FAT1 IGFBP7 GUCY1B1 TACC1	7.79e-07	190	172	8	7be4341e2909101d756f14031c21e705eb45e69a
ToppCell	Secretory\|World / shred by cell class for bronchial biopsy	MYH7B MUC16 MYO1B ANKRD36C FOXA3 LDLR FKBP2 SLC6A14	9.47e-07	195	172	8	52f8281fe0df67cec3faa780a23ed6343ed5a6ba
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNF213 SRSF11 ANKRD36C KMT2A AK1 NKTR ANKRD36 FUS	1.02e-06	197	172	8	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FLNC RELN SYNM RAPGEF4 CDH22 IGFBP7 PLCB4 EPB41L2	1.06e-06	198	172	8	9ab0db78394e730f6866b2db80047149024ad5f6
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FLNC RELN SYNM RAPGEF4 CDH22 IGFBP7 PLCB4 EPB41L2	1.06e-06	198	172	8	e47d0e2c6353315c85d7007742bb16b0f05795ed
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	SYNM MYO10 MARK1 MYO1B FAT1 IGFBP7 PLCB4 EPB41L2	1.14e-06	200	172	8	0c648941447c738caf62f2d71e296d6cca492c8b
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SYNM MYO1B SPECC1 FAT1 IGFBP7 GUCY1B1 EPB41L2 VCL	1.14e-06	200	172	8	d2fcd3bd7c3223875f027eeb48ff621192a5f242
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SYNM MYO10 MARK1 MYO1B FAT1 IGFBP7 PLCB4 EPB41L2	1.14e-06	200	172	8	522a51a284d2992d519c4669e1a48c8ebcc08c80
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA8 IGFBP7 VCAN TACC1 GPC5 FKBP5 EPB41L2 NOVA1	1.14e-06	200	172	8	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SYNM MYO10 MARK1 MYO1B FAT1 IGFBP7 PLCB4 EPB41L2	1.14e-06	200	172	8	94f1fa61aa82eb9f411b2b1cb759476939ab5db7
ToppCell	E18.5-samps-Endothelial-Mature_fetal_endothelial-capillary_endothelial_Hpgd-CA4_high\|E18.5-samps / Age Group, Lineage, Cell class and subclass	DOK1 SYNM MUC16 CHD8 ALDH1A2 TRAM1L1 HFM1	2.34e-06	154	172	7	212c340a096a3a9669d1aebd61c045cf1402a868
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MARK1 MYO1B IGFBP7 GUCY1B1 TACC1 FKBP5 EPB41L2	3.69e-06	165	172	7	3d14f37b8a9c0ddc1130e60a2e08556bad1fb855
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	FLNB MAGI3 MYO1B LDLR IGFBP7 TACC1 GPC5	4.50e-06	170	172	7	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7B CDHR2 SLC26A2 APOB FKBP5 IPMK SLC6A14	5.65e-06	176	172	7	7622f5a8e7320cc7b593141854107ecaf4adff7f
ToppCell	droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 MYH2 PPP1R1A NEFM CDH22 XIRP2 SLC6A14	6.08e-06	178	172	7	d3cbdec9d75f076e565baca05ede292cca7758a4
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SLC26A2 MUC16 ANKRD36C LDLR NKTR ALDH1A3 SLC6A14	6.31e-06	179	172	7	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	COVID-19-Heart-Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA2D1 MARK1 MYO1B SPECC1 IGFBP7 GUCY1B1 PLCB4	6.78e-06	181	172	7	33cac65ed1ea5e7bd72250495df4f850b143d5aa
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RELN FAT1 ALDH1A2 GUCY1B1 VCAN FGA PLCB4	6.78e-06	181	172	7	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RELN FAT1 ALDH1A2 GUCY1B1 VCAN FGA PLCB4	6.78e-06	181	172	7	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	CACNA2D1 MYCBP2 SLC26A2 NR3C1 ABCA8 ZNF518B EPB41L2	7.55e-06	184	172	7	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	CHD7 ANKRD36C LDLR NSD3 BBX NKTR NOVA1	7.82e-06	185	172	7	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SYNM MYO10 MARK1 MYO1B IGFBP7 GUCY1B1 TACC1	7.82e-06	185	172	7	a7dba7db79275884b2a93d8a16f2e0c739e71370
ToppCell	LV-07._Pericyte\|LV / Chamber and Cluster_Paper	MYO1B CCDC92 SPECC1 IGFBP7 GUCY1B1 TACC1 PLCB4	7.82e-06	185	172	7	acb38eba871ec72f2a8136a33b87d33b8c85465d
ToppCell	RV-07._Pericyte\|RV / Chamber and Cluster_Paper	MYO1B SPECC1 IGFBP7 GUCY1B1 TACC1 PLCB4 EPB41L1	8.10e-06	186	172	7	c533b264fbe12bc35467486fc7fbde24ba968fe1
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLIN4 CACNA2D1 FLNC MARK1 PPP1R1A FAT1 AK1	8.39e-06	187	172	7	218c9b4f28499389c43005d9626af2ac01066027
ToppCell	droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLIN4 MYH1 MARK1 MYH7B GUCY1B1 ANKRD45 EPB41L1	8.39e-06	187	172	7	59313a47a6012b2413d7d3673bb05fb7e49fd88f
ToppCell	RV-07._Pericyte\|World / Chamber and Cluster_Paper	MYO1B CCDC92 SPECC1 IGFBP7 GUCY1B1 PLCB4 EPB41L1	8.39e-06	187	172	7	dc274d6bbda619a2c914d84e2b4069cfef1739d1
ToppCell	droplet-Heart-nan-18m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLIN4 MYH1 MARK1 MYH7B GUCY1B1 ANKRD45 EPB41L1	8.39e-06	187	172	7	2591fe1552cd10925ad1d8d1f062a057ce6bdad9
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SYNM MYO10 MARK1 MYO1B IGFBP7 GUCY1B1 TACC1	8.39e-06	187	172	7	a2bf958ea59c359a265bfa437d59315e1920cdd4
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLIN4 CACNA2D1 FLNC MARK1 PPP1R1A FAT1 AK1	8.39e-06	187	172	7	c7ac4b328efc2ebb72f71154661914193ff402ca
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLIN4 CACNA2D1 FLNC MARK1 PPP1R1A FAT1 GUCY1B1	8.69e-06	188	172	7	61f010c165826b434ca3d27553d4c9e13d2c0c51
ToppCell	droplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLIN4 CACNA2D1 FLNC MARK1 PPP1R1A FAT1 GUCY1B1	8.69e-06	188	172	7	7553ef7de3575af4cf34704b405b551c1af8eb83
ToppCell	Mesenchymal-pericyte_cell\|World / Lineage, Cell type, age group and donor	SYNM MYO10 MARK1 MYO1B IGFBP7 GUCY1B1 TACC1	8.99e-06	189	172	7	d7ed96add29f219183c802895fbff519b627f635
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CLIP1 ABCA8 ALDH1A2 IGFBP7 VCAN ALDH1A3 EPB41L2	9.31e-06	190	172	7	0fea33f2dc1efa23aaa2da1c318482a52a313ff1
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNM MYO10 MYO1B IGFBP7 GUCY1B1 TACC1 EPB41L2	9.63e-06	191	172	7	1626b23a57429f835fddc052e3c57f63a4e5b8bb
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 MYH4 MYO1B PPP1R1A XIRP2 GUCY1B1 AK1	9.63e-06	191	172	7	f932980baa032748857cb367a55c37dd975c693e
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNM MYO10 MYO1B IGFBP7 GUCY1B1 TACC1 EPB41L2	9.63e-06	191	172	7	716dfa7fccbd62b5f574792e68a26dc6c45511dc
ToppCell	H1299-infected\|H1299 / Cell line, Condition and Strain	SRSF11 ANKRD36C SLTM KMT2A BOD1L1 NKTR ANKRD36	9.96e-06	192	172	7	9cf8049bdc3e0f81ce69042beac72b08d8f38b4e
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KIAA0408 PLIN4 FLNC SYNM CES1 PPP1R1A VCL	1.03e-05	193	172	7	173f1d83133f5ffa88e2a75d28835ad7acd2aa90
ToppCell	severe-low-quality_cells\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNF213 SRSF11 ANKRD36C TRIM33 AK1 NKTR ANKRD36	1.03e-05	193	172	7	9337bc93e3904c7fc7c93c328518bcd6453b1e8c
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN MYO10 ARMCX1 IGFBP7 GUCY1B1 TACC1 PEAK1	1.03e-05	193	172	7	2483bb7f398e4fa0ef09c8bd584ed25703853f03
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KIAA0408 FLNC SYNM CES1 PPP1R1A TLN1 VCL	1.03e-05	193	172	7	b1893193766ae41bf2ab6ed4083285c9c814e608
ToppCell	ASK440-Endothelial-Lymphatic\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	FLNC RELN SYNM RAPGEF4 ALDH1A2 IGFBP7 EPB41L2	1.07e-05	194	172	7	4aa68e39e36094359dfbedf1e9bdf3ea5c32ed1a
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA2D1 RAPGEF4 RTN3 CHD7 NEFM KIF5A KIF5C	1.10e-05	195	172	7	b25c534fc6320d4da6437ef1b27e32a5d5256f3e
ToppCell	NS-moderate-d_16-33-Epithelial-Secretory\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FLNB MAGI3 MYO1B FAT1 EPB41L1 VCL SLC6A14	1.14e-05	196	172	7	70384c1da9baed843f414cfd1403ddd586a2db07
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RELN FAT1 ALDH1A2 IGFBP7 GUCY1B1 VCAN FGA	1.14e-05	196	172	7	34e79918a448f6c19b87e1b1ce13c012b24be1f8
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_3\|Classical_Monocyte / Disease condition and Cell class	WASHC2A NSD3 PLIN2 VCAN TLN1 PCNX1 FKBP5	1.14e-05	196	172	7	15397ec27167bb2fb6fec120b68bf38fc71b2670
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RELN FAT1 ALDH1A2 IGFBP7 GUCY1B1 VCAN FGA	1.14e-05	196	172	7	8f82e01ca50aa4cd6149547505b4474a02fad618
ToppCell	10x3'2.3-week_14-16-Mesenchymal_fibro\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	KIAA0408 FLNC ABCA8 PPP1R1A GPC5 ALDH1A3 NOVA1	1.14e-05	196	172	7	ee45e4de9d706ec87094e87f47d3e514539b8092
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_3\|COVID-19_Mild / Disease condition and Cell class	WASHC2A NSD3 PLIN2 VCAN TLN1 PCNX1 FKBP5	1.14e-05	196	172	7	f245e929a286cb097130572e1027b4f01be8b04d
ToppCell	10x3'2.3-week_14-16-Mesenchymal_fibro-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	KIAA0408 FLNC ABCA8 PPP1R1A GPC5 ALDH1A3 NOVA1	1.14e-05	196	172	7	fa4a85a3cd52df0da5dfedc0e584e9df8c61ce89
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK1 NCOA3 MYO10 ARMCX1 IGFBP7 PEAK1 EPB41L2	1.18e-05	197	172	7	d584d0334ea97e3fa8c4cd869f5eeea2c7a1ed04
ToppCell	facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK1 NCOA3 MYO10 ARMCX1 IGFBP7 PEAK1 EPB41L2	1.18e-05	197	172	7	412091994196a06c2779b4c2cfed84be889a5f8d
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	RPLP0 SRSF11 CHD7 ANKRD36C KMT2A NKTR ANKRD36	1.18e-05	197	172	7	836dd8110d5689f944ad1d301def38c32278b5b5
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MON2 RNF213 SRSF11 ANKRD36C NKTR ANKRD36 FUS	1.26e-05	199	172	7	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Skin-Mesangial\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	PLIN4 SYNM SPECC1 GLYATL1 IGFBP7 GUCY1B1 ANKRD24	1.26e-05	199	172	7	bcb78838a91cc7828680fb413fbacdb091c5fac0
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FLNC SYNM MARK1 PSMA8 ALDH1A2 IGFBP7 KIF5A	1.26e-05	199	172	7	b768496381362f9a2706e0892b5a7a0db82e09ce
ToppCell	Frontal_cortex-Neuronal\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	ATP6V1B2 RTN3 GMPS RNF220 KIF5A KIF5C ANKRD45	1.26e-05	199	172	7	f88039d862f3bfa01dc39d2de4f3f548dc5a0e61
ToppCell	megakaryocytic-CD34+_Megakaryoblast\|megakaryocytic / Lineage and Cell class	MYCBP2 SRSF11 MDH2 IGFBP7 HADHA UQCRC2 FUS	1.26e-05	199	172	7	99a65887d3c8a2cde26693dd74404b101bba9d58
ToppCell	ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FLNB ABCA8 VCAN NKTR ALDH1A3 EPB41L2 NOVA1	1.26e-05	199	172	7	615f20bf136dfef53b072667cf0e4df6a1017e05
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SYNM MYO1B SPECC1 FAT1 IGFBP7 GUCY1B1 VCL	1.30e-05	200	172	7	b5b5a32925f225610fe25a021a742d6397162863
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FLNB RAPGEF4 RNF213 MYO1B NF1 IGFBP7 KMT2A	1.30e-05	200	172	7	2d07237022b409c4fac6fcf99b68c8affb3007cd
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MYCBP2 RNF213 SRSF11 KMT2A BOD1L1 NKTR FUS	1.30e-05	200	172	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2\|World / Primary Cells by Cluster	FOXM1 MYO10 DTL CHD7 ATAD2 PLIN2 BBX	1.30e-05	200	172	7	4923d7a4f00853c4d76fc1cc0fa82d522a2302e7
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO1B SPECC1 FAT1 IGFBP7 GUCY1B1 EPB41L2 VCL	1.30e-05	200	172	7	786f1ae53e60b5ffbf4bfd393d10b802478148b3
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2-5\|World / Primary Cells by Cluster	FOXM1 MYO10 DTL CHD7 ATAD2 PLIN2 BBX	1.30e-05	200	172	7	dc1c1506823eaa105f1532c6b5d4efa14e788314
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal\|5w / Sample Type, Dataset, Time_group, and Cell type.	RELN PPP1R1A NEFM VCAN AK1 KIF5C NOVA1	1.30e-05	200	172	7	9b5753726c17dda98d7384a60f26a5eaf4f6c4d6
ToppCell	Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_systemic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SYNM MARK1 MYO1B SPECC1 PLCB4 EPB41L1	1.83e-05	141	172	6	dcc56aef1b31bfe0de84cb0b5c77d242681cf19c
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	RNF213 ANKRD36C PCNX1 NKTR ANKRD36 FUS	2.32e-05	147	172	6	94998bc40f5c08295cfe3bdcbe43f13b1e564b3d
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	RNF213 ANKRD36C PCNX1 NKTR ANKRD36 FUS	3.23e-05	156	172	6	1545169694f686d28648a68b552c2ae606599d66
ToppCell	NS-moderate-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	KIF27 DTL RAPGEF4 DNAH7 KIF24 CC2D2A	3.35e-05	157	172	6	410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 ANKRD36C PPP1R1A XIRP2 ALDH1A3 SLC6A14	3.60e-05	159	172	6	60b1f4dce2ce0911160fda17f137c064da31e2eb
ToppCell	PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FOXM1 DTL ESRP2 RIF1 ALDH1A2 PIK3C2G	4.89e-05	168	172	6	08f6e171a1ea5cf65149744296d0fcd6c7b9684e
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	CACNA2D1 MARK1 MYO1B IGFBP7 GUCY1B1 EPB41L2	5.40e-05	171	172	6	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	Adult-Mesenchymal-pericyte_cell-D231\|Adult / Lineage, Cell type, age group and donor	SYNM MARK1 MYO1B FOXA3 IGFBP7 GUCY1B1	5.58e-05	172	172	6	858cee96c1c06160863b4adcd7023c0d678bd50f
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FOXM1 DTL ATAD2 PSMA8 KIF24 RIF1	5.58e-05	172	172	6	2b6cd84c946b1e800caba452ae70145ea285fec1
ToppCell	droplet-Liver-LIVER_HEP-30m-Lymphocytic\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 MYH2 PPP1R1A NEFM XIRP2 SLC6A14	5.95e-05	174	172	6	ecdff386d7f0bc57c170a2c1f4deae5ba7e431b5
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_progenitors\|lymph-node_spleen / Manually curated celltypes from each tissue	FOXM1 DOCK1 CES1 MALRD1 IGFBP7 VCAN	5.95e-05	174	172	6	029394e107bf7ad58056d2216070aa2e964fff12
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 MYH2 MYH4 PPP1R1A XIRP2 AK1	5.95e-05	174	172	6	4a6e04b4f12b87c15fa1409989cbe32c43736369
Computational	Genes upregulated in subsets of cells of a given type within various tumors	RNF213 ANKRD36C RIF1 FAT1 NKTR PEAK1	1.65e-05	50	118	6	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4
Drug	B0683	MYH1 MYH2 CACNA2D1 MYH4 MYO10 MYH7B MYO1B MCRS1 VCL	2.30e-07	117	169	9	CID006398969
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; HL60; HG-U133A	NCOA3 MYO10 SLC26A2 EML2 SRSF11 MED1 TTF1 FBXO38 RRP12 KMT2A NPAT	2.57e-07	196	169	11	1445_DN
Drug	S-(-)-Etomoxir	MYH1 MYH2 MYH4 CES1 MYO10 MYH7B MYO1B PLIN2	8.13e-07	100	169	8	CID000060765
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	NCOA3 MYCBP2 MYO10 SLC26A2 MED1 BBX UBN1 KMT2A NKTR FUS	9.53e-07	179	169	10	4585_DN
Drug	GSK-3 Inhibitor IX; Up 200; 0.5uM; MCF7; HT_HG-U133A	SLC26A2 CUL9 NR3C1 TRIM33 NF1 RRP12 PCNX1 KIF5C PPP6R2 OBI1	2.07e-06	195	169	10	7101_UP
Drug	formycin triphosphate	MYH1 MYH2 MYH4 MYO10 MYH7B MYO1B	2.09e-06	51	169	6	CID000122274
Drug	Sisomicin sulfate [53179-09-2]; Down 200; 2.8uM; MCF7; HT_HG-U133A	DOCK1 SLC26A2 NR3C1 ZNF623 CLIP1 NSD3 TLN1 RRP12 HMGXB3 QSER1	2.27e-06	197	169	10	2853_DN
Drug	purealin	MYH1 MYH2 MYH4 MYO10 MYH7B MYO1B	4.50e-06	58	169	6	CID006419303
Drug	bromfenacoum	CACNA2D1 RELN RPLP0 RTN3 CCDC92 MDH2 SPECC1 NDUFV3 PRKRA GMPS VCAN HADHA KIF5C UQCRC2 FKBP2 EPB41L1 RBM17	6.52e-06	644	169	17	ctd:C013418
Drug	clenbuterol	MYH1 MYH2 MYH4 MYO10 MYH7B RAPGEF4 MYO1B NUP214	1.13e-05	142	169	8	CID000002783
Drug	Panthenol (D) [81-13-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A	DOCK1 EML2 NR3C1 NF1 UBN1 TACC1 NKTR KIF5C NPAT	1.65e-05	196	169	9	7455_DN
Drug	2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA	MYO10 NSD3 KANSL3 FBXO38 NF1 RRP12 PCNX1 NKTR QSER1	1.79e-05	198	169	9	1002_UP
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A	MON2 SYNM BSDC1 RBKS KPTN SLC38A10 RRP12 PCNX1 TACC1	1.86e-05	199	169	9	5207_DN
Drug	Dibucaine [85-79-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	SRSF11 LDLR NSD3 FBXO38 TLN1 MTM1 NKTR FKBP2 FKBP5	1.86e-05	199	169	9	1469_DN
Drug	CP-113,818	CES1 APOB LDLR	2.19e-05	8	169	3	CID000164373
Drug	blebbistatin	MYH1 MYH2 MYH4 MYO7A MYO10 MYH7B MYO1B	2.59e-05	116	169	7	CID003476986
Drug	Sandoz 58-035	CES1 APOB LDLR PLIN2	2.77e-05	24	169	4	CID000122215
Drug	dimethyl succinate	FOXM1 CES1 SLC26A2 MDH2	2.77e-05	24	169	4	CID000007820
Drug	AC1L1IHP	KIF13B CACNA2D1 KIF27 MYH7B APOB NUP214 NR3C1 MED1 PSMA8 PPP1R1A NEFM NF1 PIK3C2G PYCR1 KIF5A KIF13A PPP6R2	3.14e-05	728	169	17	CID000004584
Drug	Cyclandelate	CACNA2D1 CES1	5.48e-05	2	169	2	DB04838
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA	MYCBP2 MED1 TTF1 LDLR TRIM33 UBN1 KMT2A NKTR	5.49e-05	177	169	8	985_DN
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	MYCBP2 SLC26A2 MED1 BBX UBN1 KMT2A NKTR FUS	5.71e-05	178	169	8	3998_DN
Drug	bis-diamine	FOXM1 ALDH1A2 ALDH1A3	6.35e-05	11	169	3	CID000015134
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	NCOA3 MYO10 DTL CHD7 ATAD2 WDR26 TRIM33 BBX	6.94e-05	183	169	8	7498_DN
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	NCOA3 MYO10 SLC26A2 LDLR BBX KMT2A NKTR FUS	8.38e-05	188	169	8	6735_DN
Drug	AC1MHGAG	CES1 APOB LDLR	8.41e-05	12	169	3	CID003025954
Drug	Tolbutamide [64-77-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A	KIF13B MYO10 EML2 MED1 R3HCC1L KMT2A NKTR FUS	9.02e-05	190	169	8	4362_DN
Drug	Mitoxantrone	MYCBP2 NR3C1 BBX IGFBP7 GUCY1B1 VCAN PLCB4 EPB41L2 RBM17	9.96e-05	247	169	9	ctd:D008942
Drug	orthovanadate	KIF13B CACNA2D1 ATP6V1B2 KIF27 MYO7A MYO10 MDH2 PIK3C2G DNAH17 KIF5A KIF13A VCL	1.04e-04	435	169	12	CID000061672
Drug	Betulin [473-98-3]; Down 200; 9uM; MCF7; HT_HG-U133A	IPO5 FLNC NR3C1 RIF1 R3HCC1L MTM1 HMGXB3 QSER1	1.08e-04	195	169	8	3513_DN
Drug	Gibberellic acid [77-06-5]; Down 200; 11.6uM; PC3; HT_HG-U133A	CDHR2 NUP214 NSD3 VCAN RRP12 KIF5C KIF13A CDH10	1.08e-04	195	169	8	4234_DN
Drug	SR-95639A [115767-94-7]; Down 200; 10uM; HL60; HT_HG-U133A	DOK1 NCOA3 EML2 NSD3 NF1 IGFBP7 MCRS1 PCNX1	1.08e-04	195	169	8	1336_DN
Drug	Ro 12-4825	CES1 ALDH1A2 ALDH1A3	1.09e-04	13	169	3	CID006441098
Drug	Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A	DOK1 KIF13B DMXL2 BSDC1 MYO1B NR3C1 MED1 PCNX1	1.12e-04	196	169	8	5619_DN
Drug	Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; PC3; HT_HG-U133A	MON2 EML2 TRIM33 R3HCC1L GUCY1B1 VCAN AK1 PPP6R2	1.12e-04	196	169	8	4494_DN
Drug	Viomycin sulfate [37883-00-4]; Down 200; 5.2uM; MCF7; HT_HG-U133A	FLNC NR3C1 FBXO38 NF1 TLN1 PCNX1 KIF13A FKBP5	1.12e-04	196	169	8	3541_DN
Drug	Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; MCF7; HT_HG-U133A	KIF13B EML2 LDLR NEFM RIF1 NF1 MTM1 PCNX1	1.16e-04	197	169	8	6265_UP
Drug	Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; MCF7; HT_HG-U133A	IPO5 MYO1B NR3C1 NF1 DNAH17 KMT2A AK1 KIF13A	1.16e-04	197	169	8	6105_DN
Drug	SC-58125; Up 200; 10uM; HL60; HG-U133A	KIF13B FLNC CDHR2 MYO1B MED1 RRP12 KIF5C NPAT	1.16e-04	197	169	8	542_UP
Drug	Rolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A	DMXL2 MYO1B NR3C1 KANSL3 R3HCC1L GUCY1B1 KIF5A KIF13A	1.16e-04	197	169	8	6449_UP
Drug	5707885; Down 200; 50uM; MCF7; HT_HG-U133A	MYO7A CUL9 EML2 NUP214 RIF1 NF1 EPB41L1 SLC6A14	1.16e-04	197	169	8	6385_DN
Drug	Ioversol [87771-40-2]; Down 200; 5uM; PC3; HT_HG-U133A	RBKS NF1 VCAN RRP12 AK1 KIF5C QSER1 NOVA1	1.20e-04	198	169	8	6726_DN
Drug	PHA-00816795 [212631-79-3]; Down 200; 10uM; PC3; HT_HG-U133A	MED1 NSD3 FBXO38 TRIM33 NF1 VCAN MTM1 CNPY3	1.20e-04	198	169	8	7076_DN
Drug	Bufexamac [2438-72-4]; Down 200; 18uM; MCF7; HT_HG-U133A	RBM10 NR3C1 NSD3 NF1 HMGXB3 NKTR EPB41L1 EPB41L2	1.20e-04	198	169	8	5515_DN
Drug	Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; MCF7; HT_HG-U133A	MYH2 CACNA2D1 NEFM RIF1 IGFBP7 GUCY1B1 KIF5A GPC5	1.20e-04	198	169	8	5628_UP
Drug	mono-(2-ethylhexyl)phthalate	PLIN4 KIF27 MYO7A CDHR2 ODAD4 MED1 SPECC1 PLIN2 PPP1R1A FAT1 PIK3C2G KIF5C FKBP5 EPB41L1 VCL	1.22e-04	658	169	15	ctd:C016599
Drug	Ticlopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; MCF7; HT_HG-U133A	SYNM MED1 FBXO38 R3HCC1L TLN1 TACC1 NKTR EPB41L1	1.24e-04	199	169	8	1475_DN
Drug	AC1N9ZZC	DOCK1 MYH1 MYH2 MYH4 MYH7B KIF5A VCL	1.27e-04	149	169	7	CID004369374
Drug	SC-58125; Down 200; 10uM; HL60; HG-U133A	MYO7A RBKS MED1 CLIP1 IGFBP7 MTM1 FGA PCNX1	1.29e-04	200	169	8	542_DN
Drug	Nystatine [1400-61-9]; Down 200; 4.4uM; MCF7; HT_HG-U133A	DOCK1 DOK1 DMXL2 SLC26A2 NF1 PCNX1 KIF13A EPB41L2	1.29e-04	200	169	8	4807_DN
Drug	DuP 128	CES1 APOB LDLR	1.38e-04	14	169	3	CID000071355
Drug	F 1394	CES1 APOB LDLR	1.38e-04	14	169	3	CID000178067
Disease	myopathy (implicated_via_orthology)	MYH1 MYH2 FLNB FLNC MYH4 MYH7B MTM1	9.53e-09	48	166	7	DOID:423 (implicated_via_orthology)
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	1.98e-07	10	166	4	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	1.98e-07	10	166	4	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	1.98e-07	10	166	4	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	1.98e-07	10	166	4	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	1.98e-07	10	166	4	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	1.98e-07	10	166	4	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	1.98e-07	10	166	4	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	1.98e-07	10	166	4	DOID:0080326 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	4.62e-07	12	166	4	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	4.62e-07	12	166	4	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	6.64e-07	13	166	4	DOID:397 (implicated_via_orthology)
Disease	distal arthrogryposis (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	1.26e-06	15	166	4	DOID:0050646 (implicated_via_orthology)
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 FLNC MYH4 MYH7B MED1	6.17e-06	80	166	6	DOID:12930 (implicated_via_orthology)
Disease	atelosteogenesis (is_implicated_in)	FLNB SLC26A2	3.15e-05	2	166	2	DOID:0050648 (is_implicated_in)
Disease	Atelosteogenesis	FLNB SLC26A2	3.15e-05	2	166	2	cv:C5574658
Disease	Down syndrome (biomarker_via_orthology)	RPLP0 RPLP0P6	3.15e-05	2	166	2	DOID:14250 (biomarker_via_orthology)
Disease	response to statin, LDL cholesterol change measurement	APOB LDLR EPB41L2	7.57e-05	15	166	3	EFO_0007804, GO_0036273
Disease	myofibrillar myopathy 5 (implicated_via_orthology)	FLNB FLNC	9.40e-05	3	166	2	DOID:0080096 (implicated_via_orthology)
Disease	distal muscular dystrophy 4 (implicated_via_orthology)	FLNB FLNC	9.40e-05	3	166	2	DOID:0111190 (implicated_via_orthology)
Disease	sodium-coupled monocarboxylate transporter 1 measurement	APOB LDLR ALDH1A2	1.59e-04	19	166	3	EFO_0802076
Disease	cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage	APOB LDLR ALDH1A2	2.16e-04	21	166	3	EFO_0022246
Disease	leukemia	FOXM1 NCOA3 NF1 KMT2A	2.63e-04	55	166	4	C0023418
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	APOB CCDC92 FOXA3 LDLR ABCA8 ALDH1A2 PPP6R2	2.97e-04	225	166	7	EFO_0008317, EFO_0010351
Disease	level of Phosphatidylcholine (O-18:1_16:0) in blood serum	LDLR ALDH1A2	3.11e-04	5	166	2	OBA_2045128
Disease	Coronary heart disease	APOB CCDC92 LDLR	3.24e-04	24	166	3	C0010068
Disease	lipoprotein measurement	DOCK1 CES1 APOB ABCA8 ALDH1A2	3.25e-04	105	166	5	EFO_0004732
Disease	apolipoprotein A 1 measurement, apolipoprotein B measurement	APOB CCDC92 LDLR ABCA8 ALDH1A2	3.55e-04	107	166	5	EFO_0004614, EFO_0004615
Disease	triglyceride measurement, intermediate density lipoprotein measurement	APOB CCDC92 LDLR ALDH1A2 PPP6R2	4.21e-04	111	166	5	EFO_0004530, EFO_0008595
Disease	total cholesterol measurement, high density lipoprotein cholesterol measurement	CES1 APOB CCDC92 LDLR ABCA8 CDH22 ALDH1A2 FKBP5	4.33e-04	315	166	8	EFO_0004574, EFO_0004612
Disease	free cholesterol measurement	APOB FOXA3 LDLR ALDH1A2 PPP6R2	4.56e-04	113	166	5	EFO_0008591
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	KIF27 CES1 APOB CCDC92 LDLR ABCA8 ALDH1A2	4.71e-04	243	166	7	EFO_0004612, EFO_0020944
Disease	total lipids in small VLDL	APOB CCDC92 LDLR ALDH1A2	5.62e-04	67	166	4	EFO_0022148
Disease	cortical thickness	MON2 FLNB RELN MYCBP2 CUL9 EML2 CHD7 SPECC1 ALDH1A2 MALRD1 UBN1 VCAN KMT2A TACC1 QSER1 KIF13A	5.71e-04	1113	166	16	EFO_0004840
Disease	colorectal cancer (is_implicated_in)	ABL1 CES1 RBM10 YTHDF1 FAT1	6.24e-04	121	166	5	DOID:9256 (is_implicated_in)
Disease	congenital heart disease (implicated_via_orthology)	CHD8 CHD7 RNF20 KMT2A	6.28e-04	69	166	4	DOID:1682 (implicated_via_orthology)
Disease	LDL cholesterol change measurement	APOB LDLR	6.49e-04	7	166	2	EFO_0007804
Disease	CHARGE syndrome (implicated_via_orthology)	CHD8 CHD7	6.49e-04	7	166	2	DOID:0050834 (implicated_via_orthology)
Disease	Joubert syndrome (implicated_via_orthology)	TOGARAM1 CC2D2A	6.49e-04	7	166	2	DOID:0050777 (implicated_via_orthology)
Disease	cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH7B	7.00e-04	71	166	4	DOID:0050700 (implicated_via_orthology)
Disease	triglycerides to total lipids in small HDL percentage	APOB CCDC92 ABCA8 ALDH1A2	7.38e-04	72	166	4	EFO_0022336
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	FOXM1 APOB CCDC92 FOXA3 LDLR ABCA8 ALDH1A2	7.69e-04	264	166	7	EFO_0008317, EFO_0020944
Disease	esterified cholesterol measurement, intermediate density lipoprotein measurement	APOB ALDH1A2	8.61e-04	8	166	2	EFO_0008589, EFO_0008595
Disease	Familial hypercholesterolemia	APOB LDLR	8.61e-04	8	166	2	cv:C0020445
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	KIF27 APOB CCDC92 LDLR ABCA8 ALDH1A2 HFM1	9.96e-04	276	166	7	EFO_0004612, EFO_0020943
Disease	spinal muscular atrophy (implicated_via_orthology)	KIF5A KIF5C	1.10e-03	9	166	2	DOID:12377 (implicated_via_orthology)
Disease	free cholesterol to total lipids in large VLDL percentage	APOB LDLR ALDH1A2	1.18e-03	37	166	3	EFO_0022281
Disease	acute myeloid leukemia (is_implicated_in)	ABL1 NUP214 NF1 KMT2A	1.31e-03	84	166	4	DOID:9119 (is_implicated_in)
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	CES1 APOB CCDC92 FOXA3 LDLR ABCA8 ALDH1A2	1.35e-03	291	166	7	EFO_0008317, EFO_0020946
Disease	familial hypercholesterolemia (is_implicated_in)	APOB LDLR	1.37e-03	10	166	2	DOID:13810 (is_implicated_in)
Disease	triglycerides to total lipids in large VLDL percentage	APOB LDLR ALDH1A2	1.38e-03	39	166	3	EFO_0022332
Disease	Hypercholesterolemia	CES1 APOB LDLR	1.38e-03	39	166	3	C0020443
Disease	apolipoprotein B measurement	KIF13B CACNA2D1 APOB CCDC92 LDLR ABCA8 ALDH1A2 NF1 IGFBP7 CNPY3 PPP6R2	1.39e-03	663	166	11	EFO_0004615
Disease	lipoprotein-associated phospholipase A(2) measurement	RNF213 APOB LDLR	1.48e-03	40	166	3	EFO_0004746
Disease	Moyamoya disease	DOCK1 RAPGEF4 RNF213	1.48e-03	40	166	3	MONDO_0016820
Disease	cholesterol in very small VLDL measurement	APOB LDLR ALDH1A2	1.48e-03	40	166	3	EFO_0022231
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	APOB CCDC92 LDLR ABCA8 ALDH1A2 PPP6R2	1.58e-03	220	166	6	EFO_0004529, EFO_0008317
Disease	congestive heart failure (implicated_via_orthology)	NR3C1 MED1 MDH2	1.59e-03	41	166	3	DOID:6000 (implicated_via_orthology)
Disease	lipid measurement, lipoprotein measurement	APOB LDLR ALDH1A2 PPP6R2	1.69e-03	90	166	4	EFO_0004529, EFO_0004732
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	CES1 APOB FOXA3 LDLR ABCA8 CDH22 ALDH1A2	1.70e-03	303	166	7	EFO_0004612, EFO_0020945
Disease	autistic disorder (is_implicated_in)	RELN RAPGEF4 NF1	1.71e-03	42	166	3	DOID:12849 (is_implicated_in)
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	APOB CCDC92 FOXA3 LDLR ALDH1A2 PPP6R2	1.73e-03	224	166	6	EFO_0004574, EFO_0008317
Disease	obesity (is_implicated_in)	NCOA3 INPPL1 NR3C1 SLC6A14	1.77e-03	91	166	4	DOID:9970 (is_implicated_in)
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	CES1 APOB FOXA3 LDLR ABCA8 ALDH1A2	1.77e-03	225	166	6	EFO_0008317, EFO_0020947
Disease	triglycerides in large LDL measurement	APOB LDLR ALDH1A2	1.83e-03	43	166	3	EFO_0022319
Disease	hereditary spastic paraplegia (implicated_via_orthology)	RTN3 KIF5A KIF5C	1.83e-03	43	166	3	DOID:2476 (implicated_via_orthology)
Disease	free cholesterol to total lipids in very small VLDL percentage	APOB LDLR ALDH1A2	1.83e-03	43	166	3	EFO_0022290
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	APOB CCDC92 LDLR ABCA8 ALDH1A2 PPP6R2	1.94e-03	229	166	6	EFO_0004639, EFO_0008317
Disease	concentration of large LDL particles measurement	APOB LDLR ALDH1A2	1.96e-03	44	166	3	EFO_0022160
Disease	cholesterol in medium VLDL measurement	APOB LDLR ALDH1A2	1.96e-03	44	166	3	EFO_0022225
Disease	motor neuron disease (implicated_via_orthology)	KIF5A KIF5C	2.00e-03	12	166	2	DOID:231 (implicated_via_orthology)
Disease	cholesteryl ester measurement, high density lipoprotein cholesterol measurement	CES1 APOB CCDC92 LDLR ABCA8 ALDH1A2 FKBP5	2.00e-03	312	166	7	EFO_0004612, EFO_0010351
Disease	total lipids in very small VLDL measurement	APOB LDLR ALDH1A2	2.09e-03	45	166	3	EFO_0022156
Disease	saturated fatty acids measurement	APOB LDLR ALDH1A2	2.09e-03	45	166	3	EFO_0022304
Disease	Malignant neoplasm of salivary gland	DTL FAT1 VCAN	2.09e-03	45	166	3	C0220636
Disease	cholesterol to total lipids in large VLDL percentage	APOB LDLR ALDH1A2	2.09e-03	45	166	3	EFO_0022236
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	CES1 APOB CCDC92 LDLR ABCA8 CDH22 ALDH1A2	2.12e-03	315	166	7	EFO_0004612, EFO_0008591
Disease	Colorectal Carcinoma	FLNC RBM10 EML2 MYO1B APOB ABCA8 FAT1 CDH22 NF1 MCRS1 UQCRC2	2.17e-03	702	166	11	C0009402
Disease	Endometrioma	NR3C1 MED1 NEFM VCAN FKBP5	2.22e-03	161	166	5	C0269102
Disease	Endometriosis	NR3C1 MED1 NEFM VCAN FKBP5	2.22e-03	161	166	5	C0014175
Disease	phospholipid measurement, high density lipoprotein cholesterol measurement	CES1 APOB CCDC92 LDLR ABCA8 CDH22 ALDH1A2	2.35e-03	321	166	7	EFO_0004612, EFO_0004639
Disease	Hyperlipoproteinemia Type IIb	APOB LDLR	2.36e-03	13	166	2	C1704417
Disease	Salivary Gland Neoplasms	DTL FAT1 VCAN	2.36e-03	47	166	3	C0036095
Disease	free cholesterol in small VLDL measurement	APOB LDLR ALDH1A2	2.36e-03	47	166	3	EFO_0022272
Disease	free cholesterol in very small VLDL measurement	APOB LDLR ALDH1A2	2.36e-03	47	166	3	EFO_0022275
Disease	free cholesterol in medium VLDL measurement	APOB LDLR ALDH1A2	2.36e-03	47	166	3	EFO_0022269
Disease	phospholipid measurement, intermediate density lipoprotein measurement	APOB FOXA3 LDLR ALDH1A2	2.40e-03	99	166	4	EFO_0004639, EFO_0008595
Disease	total lipids in lipoprotein particles measurement	APOB LDLR ALDH1A2	2.51e-03	48	166	3	EFO_0022309
Disease	apolipoprotein B to apolipoprotein A1 ratio	APOB LDLR ABCA8	2.66e-03	49	166	3	EFO_0021897
Disease	cholesteryl esters to total lipids in small VLDL percentage	APOB LDLR ALDH1A2	2.66e-03	49	166	3	EFO_0022256
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	APOB LDLR	2.74e-03	14	166	2	EFO_0004611, EFO_0008589
Disease	lipid measurement, high density lipoprotein cholesterol measurement	CES1 APOB CCDC92 LDLR ABCA8 CDH22 ALDH1A2	2.74e-03	330	166	7	EFO_0004529, EFO_0004612
Disease	high density lipoprotein particle size measurement	CES1 APOB CCDC92 CDH22 ALDH1A2	2.81e-03	170	166	5	EFO_0008592
Disease	triglycerides to total lipids in medium LDL percentage	APOB LDLR ALDH1A2	2.82e-03	50	166	3	EFO_0022334
Disease	L2 Acute Lymphoblastic Leukemia	ABL1 NUP214 KMT2A	2.82e-03	50	166	3	C0023453
Disease	free cholesterol measurement, intermediate density lipoprotein measurement	APOB FOXA3 LDLR ALDH1A2	2.87e-03	104	166	4	EFO_0008591, EFO_0008595
Disease	melanoma	ABL1 MYO7A MYO1B NF1 PLCB4 ALDH1A3	2.88e-03	248	166	6	C0025202
Disease	free cholesterol in large LDL measurement	APOB LDLR ALDH1A2	2.99e-03	51	166	3	EFO_0022176
Disease	triglycerides to total lipids in large LDL percentage	APOB LDLR ALDH1A2	2.99e-03	51	166	3	EFO_0022331
Disease	phospholipids in very small VLDL measurement	APOB LDLR ALDH1A2	2.99e-03	51	166	3	EFO_0022300

Protein segments in the cluster

Peptide	Gene	Start	Entry
TKDSTDISAVLGTKA	TACC1	156	O75410
EVGTVEGSTALKGFK	TTF1	366	Q15361
ESGVALTSVLVKKGD	CES1	246	P23141
HEDKDSGKTSVVVGT	ERLEC1	366	Q96DZ1
ITIESEGKGSTFAKA	CHD8	1341	Q9HCK8
GKEVIIITTDKSSSG	ANKRD34C	146	P0C6C1
KKAAVEDSGTTVETI	RNF20	21	Q5VTR2
VRTSSSGKGSILDAK	BBX	511	Q8WY36
ESGTAKKGAESVTER	VCAN	1511	P13611
GATKDAATKILSEVT	CDNF	86	Q49AH0
SVVKEKLATEGSSGA	BSDC1	56	Q9NW68
IDKIAFTGSTEVGKL	ALDH1A2	256	O94788
SEGEEKTLTGDVKTS	AKTIP	16	Q9H8T0
TGSTEVGKLVKEAAS	ALDH1A3	256	P47895
AKVSLAVTDTEKGSG	ANKRD45	176	Q5TZF3
AASGVVRLKKTATAG	SPECC1	66	Q5M775
IATEIKDGEKSGTVS	ANKRD36	736	A6QL64
ATEIKDGEKSGTVSS	ANKRD36	771	A6QL64
ATTAKAGDGSSVKEV	ATAD2	51	Q6PL18
VSGSTAKETVTVGKD	DMXL2	1401	Q8TDJ6
TKSSKIEGAGTSISE	DTL	606	Q9NZJ0
ATGAEATGAKVTETK	ANKRD24	586	Q8TF21
VEVGADTGSKSISEK	CHD7	2221	Q9P2D1
SKRGTTESKEVLSQG	R3HCC1L	106	Q7Z5L2
TIDGKTINVEFAKGS	RBM10	371	P98175
TKGASSFKITRGIEA	UQCRC2	91	P22695
TIITRDSKAKSGGTA	QSER1	1616	Q2KHR3
GSKTEVATEILDTKT	RIMBP3B	951	A6NNM3
GSKTEVATEILDTKT	RIMBP3C	951	A6NJZ7
NGETESSTAGLKVKT	INTS8	231	Q75QN2
SETSAKGLIEKVTTE	PIK3C2G	471	O75747
AAGVTISSIEKKLSA	PYCR1	96	P32322
SIATDLGKKSEETTV	NPAT	1031	Q14207
TEKVKAVDTTGAGDS	RBKS	256	Q9H477
IATEIKDGEKSGTVS	ANKRD36C	736	Q5JPF3
SVSIIATEIKDGEKS	ANKRD36C	766	Q5JPF3
ATEIKDGEKSGTVSS	ANKRD36C	771	Q5JPF3
IAREIKDGEKSGTVS	ANKRD36C	1076	Q5JPF3
QSGSGKSLEEDKVVS	OR9I1	261	Q8NGQ6
GSSAAKGTSVVKVLA	FAT1	2606	Q14517
KGTSVVKVLASDADE	FAT1	2611	Q14517
KKTSEGVTNEKGTDS	FKBP5	431	Q13451
SSLVKTAGKVDTSLE	MUC16	4781	Q8WXI7
VTKTVKGGFSETRIE	EPB41L1	811	Q9H4G0
ATGSEVRGKLETKSD	KIAA0100	2186	Q14667
ENEKGKKVTTGETSS	MAGI3	1381	Q5TCQ9
LSAVATATGAEGKRK	FKBP2	16	P26885
GSGSGEVKRTLKITD	GPC5	506	P78333
EVSSGSARGKKLSEI	AK1	46	P00568
TDRETGKLKGEATVS	FUS	326	P35637
SGAEVKKTGSSVKVS	IGHV1-45	26	A0A0A0MS14
EVVKAKAGAGSATLS	MDH2	236	P40926
VRVSVKEKGVAASSA	DDX55	221	Q8NHQ9
GSVSEVKKDSSQLGT	EPB41L2	6	O43491
ELASGVSSKGSVVKR	HMGXB3	356	Q12766
KVDTKAAGSGELGVT	FLNB	476	O75369
VTKTGNTGERFKESI	KIF27	251	Q86VH2
VKSEATGGRVTVETK	MYH7B	91	A7E2Y1
SAVSVDSKVRKDVGG	PCNX1	521	Q96RV3
VVGITFIKDSGDKGS	KPTN	96	Q9Y664
GKTRVETITGTTEGK	MUC19	7486	Q7Z5P9
TVKTEGGATLTVKDD	MYH2	61	Q9UKX2
GTSGELSVKEKTTSV	PEAK1	646	Q9H792
ITVDAKAAGEGKVTC	FLNC	1666	Q14315
GEGIRVATFSKSVKV	GLYATL1	111	Q969I3
SVGEISSKLSEKSGL	OBI1	491	Q5W0B1
SGESGAGKTESTKLI	MYO10	156	Q9HD67
VILKGSKERSTGATG	KIF24	406	Q5T7B8
NEGKTSKDGIIFSSL	KIAA0408	326	Q6ZU52
SGDKASGTAKIETAV	NUP214	1186	P35658
KTLRGGATVKVSASS	NR3C1	31	P04150
SRTETTGEKGKINVS	GUCY1B1	551	Q02153
TVQSREGGKVTAKTE	MYH1	51	P12882
EGGKVTAKTEAGATV	MYH1	56	P12882
TAKTEAGATVTVKDD	MYH1	61	P12882
ESRGEKAITQVSKGT	IGFBP7	141	Q16270
ESSTTADKEKIESGG	MON2	1081	Q7Z3U7
QSFGIKTAGLEEKST	IPO5	666	O00410
SDVQLIKTGDKVGAS	RPLP0	156	P05388
IKTGDKVGASEATLL	RPLP0	161	P05388
TANGKIESSVGKSLS	IPMK	301	Q8NFU5
GGKVIKSASATALSV	MAST1	906	Q9Y2H9
ETIKSGTSLIFKGEG	RELN	1831	P78509
TDTEKTKISGFGNTL	HFM1	1286	A2PYH4
ESVQSRELSVSGKGK	FBXO38	631	Q6PIJ6
GSKEGSVARITTSKS	MALRD1	1786	Q5VYJ5
SVATSTEGKDKDVTL	BOD1L1	1516	Q8NFC6
KGIVESSVTSAVSGK	BOD1L1	1951	Q8NFC6
GSIKDSKTEASGNIA	EFCAB5	76	A4FU69
EAGIAASITAKGESK	APOB	2786	P04114
SIESSTKGDVKGSVL	APOB	3491	P04114
IEDGTLASKTKGTFA	APOB	3936	P04114
KGTSVLTVEAVDGDK	CDHR2	256	Q9BYE9
SASLVASGKAELIKT	GMPS	376	P49915
LKKADAISSIGTSGL	CC2D2A	831	Q9P2K1
TLVQGDFDKGSKTTA	DOCK1	431	Q14185
SRVGTDKTGVKSEGS	DOK1	466	Q99704
GAGTGVSREEKVKAV	DNAH17	4186	Q9UFH2
TAIGSVKATDADTGK	CDH10	286	Q9Y6N8
GESGEKTFRTLVKSQ	CACNA2D1	581	P54289
LTVKSSEQTGDGTSK	CCDC92	66	Q53HC0
SAFEETGKTKEVIGT	CNPY3	61	Q9BT09
GTRKEVSADGKTITV	CENPJ	1176	Q9HC77
GTGKTETTKDLAKAV	DNAH7	1331	Q8WXX0
EAAGEAVLGAKTKAT	ABL1	921	P00519
AVLGAKTKATSLVDA	ABL1	926	P00519
ELRTGKEKVTSGSTT	FGA	441	P02671
LAKSSTRAKGASGVE	MCRS1	66	Q96EZ8
DVARKLGSTTVGSKS	MARK1	456	Q9P0L2
KTSKDTSASAVAVGL	HADHA	516	P40939
SIITALTAKGKESGS	FOXM1	86	Q08050
VDLAGSEKVSKTGAE	KIF5A	231	Q12840
SEKVSKTGAEGAVLD	KIF5A	236	Q12840
AGAKELTGLLTTAKS	KANSL3	686	Q9P2N6
VSKEKVVGEDVATSS	KMT2A	911	Q03164
VVGEDVATSSSAKKA	KMT2A	916	Q03164
KASAAVEKGAGATVL	CUL9	446	Q8IWT3
LKDESSSGGDVFKVT	CDH22	316	Q9UJ99
AGKTKEVIFSVEDGS	EML2	6	O95834
SETKGRAKAGSSKVI	HLTF	421	Q14527
GKEVAATGTSILKEA	SLC38A10	896	Q9HBR0
QIKTEKSGSIGAADS	HMCES	146	Q96FZ2
LKVSFSKGLGTETAE	CLIP1	641	P30622
KKTSESKNVGSTGVA	MED1	1376	Q15648
VATLGTVTKDGKTDA	PPP6R2	941	O75170
LGTEKSTDGSKDVVE	NOVA1	411	P51513
SGEKVSKVSLVDLAG	KIF13A	241	Q9H1H9
DVKSGTSGEKVGKLS	KIF13B	236	Q9NQT8
GVDTTKTVLTGTKDT	PLIN4	176	Q96Q06
ETSKAVLTGTKDAVS	PLIN4	211	Q96Q06
TGVDTSKTVLTGTKD	PLIN4	241	Q96Q06
GVDTTKTVLTGTKDT	PLIN4	506	Q96Q06
TGVDTAKTVLTGTKD	PLIN4	571	Q96Q06
AKTVLTGTKDTVTTG	PLIN4	576	Q96Q06
GVDTAKTVLTGTKDT	PLIN4	671	Q96Q06
GGLDTTKSVLTGTKD	PLIN4	736	Q96Q06
TKSVLTGTKDAVSTG	PLIN4	741	Q96Q06
TGVDTSKTVLTGTKD	PLIN4	901	Q96Q06
VDTAKTVLSGAKDAV	PLIN4	936	Q96Q06
AKGTVQTGVDASKAV	PLIN4	961	Q96Q06
GLDTTKTVLTGTKDA	PLIN4	1001	Q96Q06
KTVLTGTKDAVSAGL	PLIN4	1006	Q96Q06
TRITDSGSKTDAGKI	RUSC1	281	Q9BVN2
EKCDSLGSGVATVKV	RTN3	456	O95197
VQVFEGTSGIDAKKT	ATP6V1B2	96	P21281
SDVQLIKTGDKVGAS	RPLP0P6	156	Q8NHW5
IKTGDKVGASEATLL	RPLP0P6	161	Q8NHW5
SVKEVISAVADKLGS	RAPGEF4	691	Q8WZA2
IRKKEDVSESVGASG	TRIM33	256	Q9UPN9
TTTAALASGVEAKKG	PLCB4	896	Q15147
SVSVDVKKVQGAGGS	SYNM	981	O15061
VDLAGSEKVSKTGAE	KIF5C	231	O60282
SEKVSKTGAEGAVLD	KIF5C	236	O60282
KVLGEVGKQDSSSAS	NKTR	1186	P30414
LASAGESTGKKEVAE	NKTR	1201	P30414
GSKTEVATEILDTKT	RIMBP3	951	Q9UFD9
DGETENEGITTKTSK	RIF1	2036	Q5UIP0
TSGSAEGSLQKAEKV	ODAD4	286	Q96NG3
EEKVKKGGSGAATTT	FOXA3	216	P55318
AEVAKITAEATGKDT	NCOA3	696	Q9Y6Q9
GASGQTSESIKKSEE	SLTM	531	Q9NWH9
FTSKGLGKTLDEVTV	INPPL1	446	O15357
GEKSVQKDVSKGSIS	SEMG2	301	Q02383
EGGKVTAKTEAGATV	MYH4	56	Q9Y623
TAKTEAGATVTVKED	MYH4	61	Q9Y623
SATGKAVVEETSKLA	MYCBP2	1481	O75592
DTGKKIFAVSGLISD	RNF220	181	Q5VTB9
KATGEEFVKIAGGTS	ESRP2	331	Q9H6T0
EIEKSGGSKEATTTL	RRP12	291	Q5JTH9
DITSVAKSLGAKTVA	SDSL	221	Q96GA7
GAGKSTSIKVITGDT	ABCA8	1326	O94911
DTSEIGVETVKGAKT	ARMCX1	46	Q9P291
SAVTISKDITGGDVK	XIRP2	501	A4UGR9
SSEKVGKETSELGGS	RNF213	3511	Q63HN8
SSKKRTENGVGVETS	TRAM1L1	341	Q8N609
SVFEGDSTTAAGTKK	MTREX	11	P42285
GAIQVADKVSSGKSS	MTM1	356	Q13496
SVEKGTGDSLRESKV	SRSF11	456	Q05519
TSAALAKTLVKESTG	SLC26A2	436	P50443
TVKAVEDEATKGTRA	TLN1	2131	Q9Y490
LSTALSVEKTSKRGG	RBM17	261	Q96I25
KAAAVGTANKSTVEG	VCL	646	P18206
KTSATGGLGSIKAEV	NF1	2016	P21359
TVKTGLQKGASEISD	NSD3	611	Q9BZ95
TVGDITCTGEGTSKK	PRKRA	71	O75569
SEGKKVLVTAAAGGT	PTGR3	171	Q8N4Q0
SKTGKVQSTADIFGD	WASHC2A	471	Q641Q2
SSTEAGGEVQTSKKS	ZNF496	391	Q96IT1
DSSAKAGVSKDAIVT	UBN1	1061	Q9NPG3
TKGAVTGSVEKTKSV	PLIN2	141	Q99541
TGSVEKTKSVVSGSI	PLIN2	146	Q99541
TKALSEDSVVVVGKG	TOGARAM1	1096	Q9Y4F4
DGTKLATGSKDTTVI	WDR26	366	Q9H7D7
FVSDSNVGTGEKKVT	ZNF623	6	O75123
EAVKKGSTAVGIRGT	PSMA8	26	Q8TAA3
GKVKGKSSEATSALA	WDR35	991	Q9P2L0
SGKEVSQVVKSGFDL	SLC6A14	376	Q9UN76
TEVESRLGTSGTAKK	PPP1R1A	121	Q13522
KIGDVSSSAVKTVGS	YTHDF1	191	Q9BYJ9
SKGTSKATSEGIQEI	ZNF518B	696	Q9C0D4
GTVSVADTKGVKRKT	LDLR	496	P01130
ITGESGAGKTEASKL	MYO1B	106	O43795
ISGESGAGKTESTKL	MYO7A	156	Q13402
ISGESGAGKTETTKL	MYO7B	156	Q6PIF6
TVSLSAESGKSEKGQ	NDUFV3	31	P56181
KTVEKITSEGGDGAT	NEFM	856	P07197